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  I
Summary 
Pharmaceuticals are mainly introduced into the environment via two pathways. The first path 
is the application of veterinary drugs to animals, as they are excreted, high concentration are 
found in manure. As this contaminated manure is utilised for fertilising the fields a soil issue 
arises. The second path is the treatment of infections in the human medicine. When these 
residues are excreted they are transported through the sewers to sewage treatment plants and 
are then discharged with the treated wastewater into the aquatic environment. In this thesis the 
enviromental fate of the antibiotics erythromycin, roxithromycin, clarithromycin, tylosin, 
oleandomycin, tiamulin, salinomycin, the steroid hormones 17 β-estradiol, estrone, estriol, 
16 α-hydroxyestrone and β-estradiol 17-acetate, the hormone-conjugates β-estradiol 3-sulfate 
and estrone 3-sulfate, the oral contraceptives 17 α-ethinylestradiol and mestranol were 
studied. 
To assess the fate of the macrolide antibiotics, ionophores, pleuromutilins, steroid hormones, 
oral contraceptives and hormone-conjugates, three new analytical methods were developed in 
respect of the different matrices manure, soil and wastewater. These analytical methods are 
based on the extraction methods liquid liquid extraction (LLE), solid phase extraction (SPE) 
and accelerated solvent extraction (ASE) in combination with the clean-up steps SPE, size 
exclusion chromatography (SEC) and the detection in different ionisation modes of high 
performance liquid chromatography coupled with tandem mass spectrometry (HPLC-
MS/MS). Isotopic labelled internal standards were used to account for matrix-effects in the 
HPLC-MS/MS analysis. As the availability of deuterated macrolide antibiotics standards is 
poor, a new macrolide internal standard was synthesised. For the determination of veterinary 
pharmaceuticals the limit of quantifications (LOQ) were determined. They were between 1.4 
and 11 ng/g for manure and 0.6 to 30 ng/g in soil, whereas the LOQ in wastewater ranged 
from 0.6 to 35 ng/L . For the analysis of the steroid hormones and macrolide antibiotics in 
wastewater compliance within EU decision 657/2002/EC was achieved. 
The fate of the veterinary used antibiotics was studied with degradation experiments under 
anaerobic and aerobic conditions in manure and soil. Half-lives for antibiotics in manure 
ranged from 5 days up to >200 days and half-lives in soil ranged from 5 days up to >120 days. 
Additionally new metabolites of the antibiotic salinomycin in manure were identified by 
means of high performance liquid chromatography with electrospray ionisation coupled with 
high resolution time of flight mass spectrometry (HPLC-ESI-HR-TOF-MS) and different 
tandem mass spectrometric techniques. 
 II
The fate of steroid hormones and macrolide antibiotics during wastewater treatment was 
researched by testing the elimination efficiencies of three different concepts of STPs over four 
weeks at different weather conditions. While larger STPs eliminated hormones more 
constantly than smaller STPs, heavy rainfall events led to a collapse of the biological 
treatment step. By using trickling filter techniques for the treatment of wastewater an 
elimination of the steroid hormones could not be observed. Also no significant elimination of 
macrolide antibiotics during wastewater treatment could be detected in all three STPs. 
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Introduction 
 1
1 Introduction 
Over 2,900 different medical substances are registered in Germany [1]. These 
pharmaceuticals are administered orally, intravenously or applied onto the skin depending on 
the compound itself and the medical circumstances. The fate of these drugs following 
application were long time neglected. Only when different drugs were detected in the 
environment [2, 3, 4], toxic effects on fauna, flora and environmentally relevant bacteria has 
been observed [5, 6, 7, 8, 9] and a resistance of bacteria to the majority of existing antibiotics 
were detected [10, 11] it came to a rethinking in policy and society. 
1.1 Pathways of pharmaceuticals into the environment 
Pharmaceuticals enter the environment by different routes (Figure 1). Two paths are 
prevalent. Pharmaceuticals used in human medical medicine (path A) are excreted 
metabolised or unmetabolised via the urine and faeces shortly after administration [12]. 
 
Figure 1: Sources, distribution and sinks of pharmaceuticals in the environment according to 
Kümmerer [13] 
production
application of
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These substances enter the sewage treatment plants via municipal sewage systems. If these 
drugs and their metabolites are not eliminated during the wastewater treatment processes, they 
enter the aquatic environment. Pharmaceuticals have been detected in several German rivers 
[14, 15, 16]. Also Weigel et al. and Buser et al. found clofibric acid, a metabolite of 
clofribrate, in the German Bight of the North Sea [17, 18, 19]. Pharmaceuticals could be even 
detected in German drinking water, as well as in groundwater [20, 21, 22]. 
A similar issue has risen in industrial agriculture. Veterinary drugs used in animal husbandry 
for the treatment and prevention of infections or to promote the weight of the animals [23]. 
They are excreted unchanged or metabolised with the manure (path B). After storing the 
manure several months in manure tanks, farmers use this stored manure to fertilise their 
fields. Also digested sewage sludge is used to fertilise fields. Thus the drug residues which 
are contained in the manure and sludge are introduced to the soil. Heavy rainfalls may wash 
these drug residues from the soil and they may thus enter the aquatic environment. Also 
antibiotics can inhibit the biogas production during the anaerobic digestion of liquid manure 
[24]. Additionally veterinary drug residues can enter edibles e.g. residues in eggs and meat. 
The food monitoring is part of the national food and drug administration and sometimes 
international affairs are taking place. In 2002 the European Union stopped the import of 
Chinese shrimps because of high levels of chloramphenicol, an antibiotic, in these shrimps 
[25, 26]. 
This work was performed to understand the environmental occurrence and fate of drugs. The 
first part focuses on the exposition route of veterinary drugs (path B), the occurrence and fate 
of veterinary used antibiotics in manure and soil. The second part of the work describes the 
exposure and fate of human medical drugs like steroid hormones and antibiotics in different 
sewage treatment plants (path A). As no methods for the determination of these drugs in these 
three matrices existed, new analytical methods had to be developed for the determination of 
veterinary and human drugs as well as steroid hormones in manure, soil and wastewater. 
Introduction 
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1.2 Choice of the analytes 
As representative analytes for the veterinary path (B), the veterinary used antibiotics 
erythromycin, tylosin, oleandomycin, salinomycin and tiamulin were chosen. Tiamulin and 
salinomycin were used by the cooperating farmers. Additionally roxithromycin, at present 
exclusively used in human medicine, was chosen because roxithromycin may be approved for 
veterinary medicine applications in future. As sulfonamides and tetracyclines were actually 
studied by other groups these antibiotics were excluded in this work. 
The behaviour of pharmaceuticals at the human path (A) is described by the steroid hormones 
17 β-estradiol, estrone, estriol, 16 α-hydroxyestrone and 17 β-estradiol 17-acetate, the 
hormone-conjugates β-estradiol 3-sulfate and estrone 3-sulfate, the oral contraceptives  
17α-ethinylestradiol and mestranol and the common used macrolide antibiotics erythromycin, 
roxithromycin and clarithromycin. 
The subsequent tables show the structural and empiric formula, the monoisotopic mass (MW), 
the chemical abstract registry number (CAS) as well as the consumption of these compounds. 
The consumption of the veterinary used (vet) drugs tiamulin, erythromycin and tylosin, is 
based on the data of Broll et al. for Schleswig-Holstein [27]. This dataset was extrapolated to 
the whole of Germany by the assumption that Schleswig-Holstein’s pig fattening is only 5 % 
of those of Germany. These data stems from the Federal Statistical Office of Germany [28]. 
Data on the consumption of the human used (hum) antibiotics and hormones in Germany is 
derived from the report of “Bund/Länderausschuss für Chemikaliensicherheit (BLAC), 
Arzneimittel in der Umwelt” as far as available [29]. The usage and sources into the 
environment of the analytes were compiled by using books about pharmacology [30], the 
drug catalog ‘Rote Liste’ [1] and a food chemistry encyclopaedia [31]. 
Introduction 
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Table 1: Erythomycin 
Macrolide antibiotic 
O
O
O
OHHOHO
O
O
O
N
HO
O
O
OH  
Empirical formula: 
C37H67NO13 
 
MW: 733.46 
 
CAS [111-07-8] 
 
Consumption: 
hum: 19 tons  
vet: 20 kg  
Usage: In human medicine for the treatment of infections like scarlatina, tonsillitis, erysipelas, 
pneumonia, diphtheria, pertussis, acne vulgaris and for the prevention of the rheumatic fever. 
In veterinary medicine for the treatment of intestinal infection, mastitis and pneumonia. 
 
Table 2: Oleandomycin 
Macrolide antibiotic 
O
OH
O
O
OH
N
O
O
O
O
O
HO
O
 
Empirical formula: 
C35H61NO12 
 
MW: 687.42 
 
CAS [7060-74-4] 
 
Consumption: 
hum: na 
vet: na 
Usage: Oleandomycin is used in human and veterinary medicine. It has a similar application 
range as erythromycin, but with smaller effects. Primarily used for the treatment of mastitis 
and skin diseases in veterinay medicine. Mostly used as oleandomycinphosphate. 
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Table 3: Tylosin 
Macrolide antibiotic 
O
O
O OH
O
O
OH
N
O
OO
HO
O
O
O
HO
OH
O
Empirical formula: 
C46H77NO17 
 
MW: 915.52 
 
CAS [1401-69-0] 
 
Consumption: 
hum: - 
vet: 6.4 tons  
Usage:  
Treatment of dysentery at pigs as well as feed additive to promote the growth of pigs until 
1998. Mostly used as tylosintartrate. 
 
Table 4: Roxithromycin 
Macrolide antibiotic 
O
N
O
OHHOHO
O
O
O
N
HO
O
O
OH
O
O
O
 
Empirical formula: 
C41H76NO15 
 
MW: 836.52 
 
CAS [80241-83-1] 
 
Consumption: 
hum: 9.5 tons  
vet: - 
Usage:  
This oxime derivative of erythromycin has a similar application range as erythromycin, but it 
is only used in human medicine. 
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Table 5: Clarithromycin 
Macrolide antibiotic 
O
O
O
OHOHO
O
O
O
N
HO
O
O
OH  
Empirical formula: 
C38H69NO13 
 
MW: 747.48 
 
CAS [81103-11-9] 
 
Consumption: 
hum: 7.2 tons  
vet: - 
Usage:  
This methylether derivative of erythromycin has a similar application range as erythromycin 
but it is only used in human medicine. 
 
Table 6:Tiamulin 
Pleuromutilin derivative 
N
S
O
O
OH
O  
Empirical formula: 
C28H47NO4S 
 
MW: 493.32 
 
CAS [55297-96-6] 
 
Consumption: 
hum: - 
vet: 9.2 tons  
Usage: This pleuromutilin derivative is only used in veterinay medicine for the prevention and 
treatment of the enzootic pneumonia, dysentery and sinusitis. Mostly used as the water soluble 
tiamulin hydrogen fumarate, tiamutin®. 
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Table 7: Salinomycin 
Ionophore 
O O
OH O
O
O O
OH
OH
O
OH
 
Empirical formula: 
C42H70O11 
 
MW: 750.49 
 
CAS [53003-10-4] 
 
Consumption: 
hum: - 
vet: na 
Usage: Salinomycin is used to promote the growth of pigs and as feed additive for the 
prevention and treatment of the coccidiosis. Mostly used as the water soluble sodium 
salinomycin. 
 
Table 8: 17 β-Estradiol 
Steroid hormone 
OH
HO
H
H
H
 
Empirical formula: 
C18H24O2 
 
MW: 272.18 
 
CAS [50-28-2] 
 
Consumption: 
hum: 1.1 tons  
vet: - 
Usage: Hormonal treatment for ailments in the climacteric period of women and prevention of 
the osteoporosis. 17 β-Estradiol is a natural steroid hormone and mainly excreted in the urine 
of mammals. 
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Table 9: Estrone 
Steroid hormone 
O
HO
H
H
H
 
Empirical formula: 
C18H22O2 
 
MW: 270.16 
 
CAS [53-16-7] 
 
Consumption: 
hum: 0 kg  
vet: - 
Sources:  
Estrone is a metabolite of estradiol and mainly excreted with the urine of mammals. 
 
 
Table 10: Estriol 
Steroid hormone 
OH
HO
H
H
H
OH
 
Empirical formula: 
C18H24O3 
 
MW: 288.17 
 
CAS [50-27-1] 
 
Consumption: 
hum: 160 kg  
vet: - 
Usage: Hormonal treatment for ailments during the female menopause and prevention of the 
osteoporosis. Estriol is a metabolite of estradiol and mainly excreted with the urine of 
mammals. 
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Table 11: 16 α-Hydroxyestrone 
Steroid hormone 
O
HO
H
H
H
OH
 
Empirical formula: 
C18H22O3 
 
MW: 286.16 
 
CAS [566-76-7] 
 
Consumption: 
hum: - 
vet: - 
Sources:  
16 α-Hydroxyestrone is a metabolite of estradiol and mainly excreted with the urine of 
mammals. 
 
 
Table 12: β-Estradiol 17-acetate 
Steroid hormone 
O
HO
H
H
H
O
 
Empirical formula: 
C20H26O3 
 
MW: 314.19 
 
CAS [1743-60-8] 
 
Consumption: 
hum: - 
vet: na 
Usage:  
Hormonal treatment for ailments during the female menopause and prevention of the 
osteoporosis. 
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Table 13: β-Estradiol 3-sulfate 
Hormone-conjugate 
OH
O
H
H
H
S
HO
O
O  
Empirical formula: 
C18H24O5S 
 
MW: 352.13 
 
CAS [481-96-9] 
 
Consumption: 
hum: - 
vet: - 
Sources:  
β-Estradiol 3-sulfate is a conjugate of estradiol, formed in the bile and mainly excreted with 
the urine of mammals. 
 
 
Table 14: Estrone 3-sulfate 
Hormone-conjugate 
O
O
H
H
H
S
HO
O
O  
Empirical formula: 
C18H22O5S 
 
MW: 350.12 
 
CAS [481-97-0] 
 
Consumption: 
hum: - 
vet: - 
Sources:  
Estrone 3-sulfate is a metabolite of estradiol and a conjugate of estrone, formed in the bile and 
mainly excreted with the urine of mammals. 
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Table 15: 17 α-Ethinylestradiol 
Oral contraceptive 
OH
HO
H
H
H
 
Empirical formula: 
C20H24O2 
 
MW: 296.18 
 
CAS [57-63-6] 
 
Consumption: 
hum: 50 kg  
vet: na 
Usage:  
Primary used for the oral contraception in human medicine also used for the contraception in 
veterinary medicine (pet care). Not used in the European industrial animal husbandry.  
 
Table 16: Mestranol 
Oral contraceptive 
OH
O
H
H
H
 
Empirical formula: 
C21H26O2 
 
MW: 310.19 
 
CAS [72-33-3] 
 
Consumption: 
hum: 0.8 kg 
vet: - 
Usage:  
Primary used for the oral contraception in human medicine also used for the contraception in 
veterinary medicine (pet care). Not used in the European industrial animal husbandry. 
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2 Determination and elimination of selected 
antibiotics in liquid manure 
2.1 Introduction to antibiotics in manure 
Most of the 2,900 pharmaceuticals registered in Germany were used in animal husbandry as 
well as in human medical applications [1]. In the recent years the occurrence of these 
pharmaceuticals in the agricultural environment has been reported [15, 32, 33]. Additionally, 
the occurrence of antibiotics in influents, effluents and sludge of sewage treatment plants [34, 
35] and surface waters [14, 36] has been discussed. Toxic effects on fauna have been 
observed as well [5]. Furthermore, bacterial resistance to the majority of existing antibiotics 
were first reported by Neu [10]. 
Over 10,000 tons of antibiotics were applied in Europe in 1997 as antibacterial agents. About  
50 % is used in human medicine while the other half is applied in large-scale animal 
husbandry [37]. The veterinary antibiotic classes such as tetracyclines, sulfonamides, 
macrolides, ionophores and pleuromutilins are commonly used to treat infections in livestock. 
Three different uses of antibiotics are currently considered significant in, e.g., pig farming.  
 
1.) The treatment of infections; e.g. with pleuromutilins and macrolides,  
2.) Disease prevention; especially if pigs from different breeders are brought together for 
fattening, e.g. pleuromutilins and macrolides 
3.) Growth promotion; which is the continuous dosing of an antibiotic compound, such as 
salinomycin, to pigs in order to promote growth during the fattening phase. Sodium-
monensin, sodium-salinomycin, flavophospholipol and avilamycin are currently used for 
growth promotion in agriculture, but these antibiotics will probably be phased out in the EU 
on January 1st, 2006 [38]. Sodium-salinomycin is still allowed as feed additive for pigs until 
October 2009 [39] and for the prevention of coccidiosis until August 2014 [40].  
 
A typical pig farm in Germany holds an average of 800 pigs [28]. Depending on the actual 
infections in the livestock, about 1-5 kg of each of the antibiotics are used during the fattening 
phase on such a farm. The pigs quickly absorb most of the compounds and excrete 50-90% 
(ß-lactam-antibiotics, tetracyclines, sulfonamides) of the initial amounts after several days 
[12]. The respective parent compound as well as their primary metabolites are prevalent in 
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excretions. Thus, large quantities of the pharmaceuticals are transferred to manure tanks, 
along with the liquid manure. After the storage, the manure is dispersed on the fields and the 
unmetabolised antibiotics contained in this manure may contaminate the soil and eventually 
the ground water. The occurrence and fate of veterinary drugs such as sulfonamides and 
tetracyclines in soil or manure has been reported [41, 42, 43]. Basic considerations about the 
fate of veterinary drugs have also been published by Tolls [44]. 
However, little is known about the fate of antibiotics in manure. In this medium they may 
undergo diverse reactions resulting in complete or partial elimination of the parent compound 
[45]. Three different degradation behaviours are possible:  
1) Complete elimination by mineralisation of the antibiotics.  
2) Partial transformation. 
3) Persistence of the compounds in the manure.  
These processes can be performed by biotic or abiotic means.  
While the published literature focuses on sulfonamides and tetracyclines, the aim of this study 
was the development of a reproducible and sensitive multiresidue method to investigate the 
commonly used macrolides erythromycin, roxithromycin, and oleandomycin, the ionophore 
salinomycin as well as the pleuromutilin derivative tiamulin in liquid swine manure. 
Furthermore this study focuses also on the fate of these antibiotics during storage of liquid 
manure until the manure is spread on agricultural fields.  
Manure may be stored about 180 days before being dispersed on fields [46] and is most often 
stored in anaerobic lagoons or storage tanks. Manure storage in ‘anaerobic lagoons’, typically 
used in the United States and Canada, are large outdoor basins of liquid manure, with air and 
sunlight on the surface but anaerobic in depth. Therefore, some oxygen may diffuse into the 
lagoon and sunlight may cause photo-transformations of antibiotics at the surface.  
Manure storage tanks are more commonly used in Europe. In a manure tank, manure is stored 
in the dark and has reduced air admittance. In these tanks there are more anaerobic conditions 
than in lagoons. 
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2.2 Method development and validation 
2.2.1 Experimental to antibiotics in manure 
2.2.1.1 Chemicals to antibiotics in manure 
Acetonitrile (HPLC-S gradient grade) was purchased from Biosolv (Valkensward, 
Netherlands). Water (HPLC grade) was obtained from Mallinckrodt Baker (Griesheim, 
Germany). Isooctane, methanol (Suprasolv grade), acetone, ethyl acetate, methylenchloride, 
chloroform, triethylamine, ammonium acetate, ammonium hydroxide, dipotassium hydrogen 
phosphate, potassium dihydrogen phosphate, urea, disodium ethylenediaminetetraacetate, 
sodium sulfate, and calcium carbonate (analytical grade) were obtained from Merck 
(Darmstadt, Germany). Erythromycin, roxithromycin and O-methylhydroxylamine 
hydrochloride were provided by Sigma-Aldrich (Seelze, Germany). Oleandomycin phosphate 
dihydrate, sodium salt, salinomycin SV sodium salt 2.5-hydrate, tiamulin fumarate 
(VetranalTM) and sodium chloride (analytical grade) were obtained from Riedel-de Haën 
(Seelze, Germany). 
2.2.1.2 Internal standard 
The synthesis of (E)-9-[O-(2-methyloxime)]-erythromycin was similar to the procedure 
described by Gasc et al. [47]. 
1,052 mg of calcium carbonate and 415 mg of O-methylhydroxylamine hydrochloride were 
added to a solution of 707 mg erythromycin in dry methanol and the mixture was stirred at 
room temperature for 96 hours. This solution was poured into 50 mL of an  
5 % ammonium hydroxide solution and the resulting mixture was cooled in an ice-water bath. 
The mixture was extracted thrice with 30 mL methylene chloride.  
The crude product was purified by chromatography on silica gel 60 with a chloroform : 
triethylamine mixture (9:1, v/v). The HPLC-MS separation of the derivative revealed a purity 
of 92% at mass 763.5. MS conditions were full scan from 150 to 1000 amu, device 
parameters are described in 2.2.1.7. No erythromycin was detected. The 1H-NMR signals of 
the modification (300 MHz, CDCl3) reveal δ 3.83 ppm (s, N-OCH3) and δ 3.33 ppm (s, 4’’-
OCH3). This is in agreement with the data from the literature [47]. This new macrolide was 
used as internal standard (IS-A). Figure 2 shows the structural formula of the new internal 
standard. 
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Figure 2: Structural formula of the new internal standard, (E)-9-[O-(2-methyloxime)]-
erythromycin 
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N
O
OHHOHO
O
O
O
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O
O
OH
O
 
 
2.2.1.3 Sample pre-treatment 
The manure was homogenised for 5 min at 25,000 rpm using an ultra turrax homogeniser 
(VF2 / IKA, Staufen, Germany). 15 g of homogenised  manure were transferred into 75 mL 
centrifuge glass tubes with a screw cap (Schott, Mainz, Germany) and 5 g urea was added. 
The samples were buffered to pH 8 by the addition of 6 mL phosphate buffer (3.4 g K2HPO4, 
0.1 g KH2PO4 dissolved in 100 mL HPLC-grade water). 
 
2.2.1.4 Liquid-liquid extraction 
The buffered manure was extracted with 40 mL ethyl acetate by shaking for 20 min on a 
horizontal shaker (Kottermann, type 4020, Haenigsen, Germany) at 150 min-1. After shaking, 
before phase separation, 25 µL of internal standard solution (10 mg  
(E)-9-[-O-(2-methyloxime)]- erythromycin dissolved in 100 mL acetonitrile) was added to the 
mixture and the centrifuge glass was shaken by hand for 1 min. The phases were separated by 
centrifugation at 800 g (1,350 rpm) for 20 min (BeckmannCoulter, Avanti J25, 
Unterschleissheim, Germany). The organic phase was removed and stored. The aqueous 
phase was mixed with 6 mL EDTA solution (3.7 mg disodium ethylenediaminetetraacetic 
acid dissolved in 100 mL HPLC-grade water) and the mixture was extracted again with 
40 mL ethyl acetate, with shaking (20 min) and centrifugation (800 g for 20 min). The organic 
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phases from both extractions were combined and the sample volume was reduced to 5 mL by 
means of a rotary evaporator at 60 °C and 320 mbar. The residue was dissolved in 20 mL 
isooctane and the volume was reduced again to 10 mL at 60 °C and 170 mbar. Figure 3 shows 
the procedure for analysis of antibiotics in manure. 
 
Figure 3: Sample preparation manure 
15 g manure
 
1  extractionst
2  extractionnd
aqueous
add 6 ml EDTA
solvent
40 mL ethylacetate
solvent
40 mL ethylacetate
+ 5 g urea
+ 6 mL phosphate buffer (pH 8) 
+ internal standard
clean up
HPLC-
APCI -MS/MS+
diol SPE
wash:
elute:
6 mL water
 8 mL acetonitrile /  0.1 M
 aqueous ammoniumacetate (3:2)
evaporate 
 solvent
 
 
2.2.1.5 SPE clean-up 
Samples were cleaned up by a modification of the method developed by Delépine et al. [48]. 
Diol solid-phase extraction cartridges from UCT (2,000 mg, Bristol/PA, USA) were 
conditioned once with 10 mL isooctane at a flow rate of 5 mL/min. A solid-phase extraction 
manifold (IST, Grenzach-Wyhlen, Germany) with PTFE stopcock and outlet, was used. The 
manure extract (10 mL) was passed through the cartridge at a speed of 5 mL/min (vacuum). 
The cartridge was washed once with 10 mL isooctane to remove lipids and dried for 20 min 
by sucking air through the column followed by a wash step with 10 mL water to remove salt. 
The analytes were eluted twice from the cartridge with 4 mL (3/2, v/v) mixture of 
acetonitrile:0.1 M aqueous ammonium acetate solution at a flow rate of 5 mL/min. An aliquot 
of 0.8 mL of the eluate was transferred to a 1.5-mL autosampler vial for HPLC-MS/MS 
analysis. 
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2.2.1.6 HPLC 
The HPLC separations were performed using a Phenosphere-Next RP18 column (2 mm i.d., 
length 150 mm, particle size 3 µm) and a SecurityGuard (Phenomenex, Torrance, CA, USA) 
at 25 ± 1 °C. The flow rate was 0.2 mL/min. The HPLC gradient was established by mixing 
two mobile phases: phase A, 10 mM aqueous ammonium acetate solution and phase B, pure 
acetonitrile. Chromatographic separation was achieved with the following gradient: 0-1 min 
10% B, 1 min to 14 min 10% to 100% B, 14-29 min 100% B, 29 min to 30 min 100% to 10% 
B, 30-35 min 10% B. Ten µL of each sample were injected. 
The HPLC system consisted of a GINA 50 autosampler, a P 580A HPG HPLC pump, a 
degasser unit DEGASYS DG-1210 and a column oven STG 585 (all from Dionex, Idstein, 
Germany). The dead time of the HPLC system was 1.8 min.  
 
2.2.1.7 Mass spectrometry 
The triple quadrupole mass spectrometer (TSQ 7000, Finnigan-MAT, Bremen, Germany) was 
equipped with an APCI 2 source and operated under the following conditions: capillary 
temperature, 180 °C; sheath gas, 40 psi; corona current, 5 µA; vaporizer temperature, 450 °C; 
auxiliary gas, off; q0 offset, -4.4 V; collision cell pressure, 2.0 mTorr; collision gas, argon; 
multiplier, 1900 V. The potential difference between the capillary and the tube lens was held 
at 70 V. The cycle time was 1.0 s during the chromatographic determination of antibiotics. 
The data obtained were processed using XcaliburTM 1.2 software. The silica capillary of the 
APCI 2 source was replaced by a steel capillary in order to reduce tailing of antibiotics 
adsorbing on the silica surface [49]. While the electrospray ionisation is vulnerable to matrix 
effects, APCI was preferred [50, 51]. 
A post-column Valco divert valve was used to direct most of the non-significant HPLC flow 
of a sample to waste. Diverting the flow minimised contamination of the MS source: 0-8 min 
divert to waste, 8-28 min flow to mass spectrometer, 28-35 min divert to waste. An additional 
flow of 50 µL/min water acetonitrile (3:7, v/v) pumped by a LC-10 AT HPLC (Shimadzu, 
Duisburg, Germany) compensated the missing flow from the HPLC during waste positing 
operation. Automatic data acquisition was triggered using a short contact closure signal of the 
autosampler. 
To gain higher selectivity, selected reaction monitoring (SRM) was chosen. Key parameter 
settings for SRM are given in Table 17.  
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Table 17: SRM data and retention time of macrolides, ionophores and tiamulin 
 RT 
[min] 
parent ion 
[amu] 
daughter ion 
[amu] 
collision energy 
[eV] 
Oleandomycin 11.0 688.5 544.5 -20 
Erythromycin 11.4 734.5 576.5 -22 
Roxithromycin 12.9 837.5 679.5 -25 
Internal standard 13.1 763.5 605.5 -24 
Tiamulin 13.6 494.6 192.3 -27 
Salinomycin 24.1 768.7 733.6 -22 
 
2.2.1.8 Calibration 
The calibration was performed as an internal standard calibration in the presence of manure 
matrix to account matrix effects [50, 51]. A liquid manure sample with a very high dissolved 
organic carbon (8.4 mg/mL) content and a relative high dry weight (11 %) was selected from 
an organic-pig farm to simulate a worst-case scenario. This antibiotic-free manure had a pH of 
7.7. The cleaned-up extracts of this manure were used for preparation of the standards in the 
presence of manure matrix for HPLC-MS/MS determination. 
A stock solution was produced by dissolving 10 mg of the macrolides, ionophores and 
tiamulin in 100 mL acetonitrile. This standard solution was stored at 4 °C in the dark and was 
stable for at least 3 months. Calibration standards (5, 10, 50, 100, 500, 1,000 and 5,000 
ng/mL) were made by serial dilution of the stock solution. The internal standard solution was 
added to the calibration standards in a concentration of 500 ng/mL. The calibration standard 
solution (0.5 mL) was filled in 1.8-mL HPLC vials and 0.5 mL manure matrix were added. 
The manure matrix solution was produced by the established method described above. The 
calibration curves were calculated using a weighted (1/X) linear regression model. 
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2.2.2 Results and discussion to antibiotics in manure 
All analytes were completely separated by HPLC. The selected APCI SRM traces for 
quantification are shown in Figure 4. 
 
Figure 4: APCI SRM traces of selected macrolides, ionophores and tiamulin for 
quantification in spiked manure (600 µg/kg) 
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Oleandomycin:                                                 688.5 ---> 544.5 @ -22eV
Erythromycin:                                                  734.5 ---> 576.5 @ -20eV
Roxithromycin:                                                837.5 ---> 679.5 @ -25eV
Tiamulin:                                                         494.6 ---> 192.3 @ -27eV
Salinomycin:           768.7 ---> 733.6 @ -22eV
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time / min
Internal standard:                                             763.5 ---> 605.5 @ -24eV
RT: 13.6
RT: 24.1
RT: 13.1
RT: 12.9
RT: 11.4
RT: 11.0
 
 
The calibration graphs are linear in the range from the limit of quantification (LOQ) up to 
5,000 ng/mL with regression coefficients (R2) better than 0.98 (Table 18). 
Antibiotics in liquid manure 
 20
 
Table 18: Calibration curve (with intercept and slope) and regression coefficient (R2) of the 
weighted (1/X) matrix calibration with atmospheric pressure chemical ionisation in SRM 
mode 
 
intercept 
[Area ratio] 
slope 
[Area ratio/ng·ml-1] 
R2 
Erythromycin   -592.4 · 10-5           190 · 10-5  0.993 
Oleandomycin   -276.3 · 10-5           273 · 10-5  0.997 
Roxithromycin   -560.7 · 10-5           210 · 10-5  0.998 
Salinomycin   -991.2 · 10-5          77.9 · 10-5 0.991 
Tiamulin    -2466 · 10-5           975 · 10-5  0.998 
 
 
2.2.2.1 Validation of the method 
The method was validated by spiking 15 g of homogenised antibiotic-free manure, as 
described above, with aliquots of 0.3-300 µl of the stock solution (2, 6, 20, 200 and 2,000 
µg/kg manure) and shaking manually for 1 min. The following sample preparation, extraction 
and clean-up was identical to the procedures described above. 
Recovery experiments for the macrolides, ionophores and tiamulin were carried out at five 
concentrations levels in triplicate.  
The recoveries are given in Figure 5. Since there was no significant concentration (2, 6, 20, 
200 and 2,000 µg/kg) dependency of the recovery rates, all results of all recovery experiments 
were averaged (Table 19). 
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Figure 5: Recovery rates of tiamulin and roxithromycin at five concentration levels (2, 6, 20, 
200 and 2,000 µg/kg manure) The standard deviation (SD) for three replicates is indicated by 
an error bar, the standard deviation of the validated method is indicated by a dashed line. 
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Table 19: Mean recovery, standard deviation (SD), relative standard deviation (RSD), limit 
of detection (LOD) and limit of quantification (LOQ), (three extractions, repetitions for each 
concentration level) of macrolides, ionophores and tiamulin in manure. Recoveries were 
determined at concentrations of 2, 6, 20, 200 and 2,000 µg/kg manure. LOD: S/N = 3:1, LOQ: 
S/N = 10:1 
  
Mean 
recovery 
SD RSD 
LOD 
[µg/kg] 
LOQ 
[µg/kg] 
Erythromycin 94% 34% 36% 1.0 3.4 
Oleandomycin 75% 16% 21% 0.4 1.4 
Roxithromycin 78% 20% 15% 0.8 2.7 
Salinomycin 119% 26% 22% 3.2 11 
Tiamulin 123% 18% 15% 0.4 1.4 
Ivermectin n.v. - - 28 93 
Monensin n.v. - - 18 60 
Tylosin n.v. - - 20 68 
n.v.: not validated 
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Mean recoveries of 75% (RSD 21%) to 94% (RSD 36%) were obtained for the macrolides, 
the recovery of salinomycin was 119% (RSD 26%) and of tiamulin 123% (RSD 15%). The 
limit of detection (LOD) was taken as a signal-to-noise ratio of 3:1 and the limit of 
quantification (LOQ) was defined as a signal-to-noise ratio of 10:1 (Table 19). This method 
was also applied to ivermectin, monensin and tylosin, but did not give constant recovery rates 
for these three compounds. 
 
2.2.2.2 Application to environmental samples  
The method was tested for several samples in order to investigate the persistence of 
antibiotics in different manure samples. One of the four samples investigated contained 
tiamulin (43 µg/kg) and salinomycin (11 µg/kg). Figure 6 shows the SRM trace of the manure 
sample which contained tiamulin and salinomycin.  
 
 
Figure 6: APCI SRM traces of a manure sample from a farm, that applied tiamulin and 
salinomycin. Tiamulin (43 µg/kg) and salinomycin (11 µg/kg) were measured. 
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Tiamulin:          494.6 ---> 192.3 @ -27eV
Salinomycin:          768.7 ---> 733.6 @ -22eV
RT: 13.6
RT: 24.1
 
 
Additionally the respective farmer gave the information that both compounds had been 
applied two months before sampling, together with information on dosage. The manure was 
stored several months, before it was homogenised in the manure tank and successively 
sampled. This manure had a dry weight of 5 % and the total organic carbon was 29 mg/mL. 
The concentrations of tiamulin and salinomycin were two orders of magnitude lower than the 
expected concentrations of 2,000 µg/kg manure [52, 53]. This expected concentration is based 
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on the assumption that the administered dosage of 2 kg antibiotic is excreted completely by 
the 800 pigs and the whole liquid manure was deposited in the 1,000 m3 manure tank.  
These antibiotics are probably not very stable in manure. Time and temperature-dependent 
degradation experiments are necessary to obtain more information about the long-term 
stability of these compounds in manure (see chapter 2.3).  
 
2.3 Manure degradation experiment 
2.3.1 Experimental to the manure degradation experiment 
Chemicals, sample pre-treatment, liquid-liquid extraction, SPE clean-up, HPLC and mass 
spectrometry conditions were the same as described above (see chapter 2.2.1.) 
2.3.1.1 Manure 
Ten litre liquid manure were collected in May 2002 directly from the manure tank of a local 
farmer. The manure in the tank was stirred for about 20 minutes before sampling. The 
temperature of the liquid manure was about 18 °C.  
There was no application of erythromycin, roxithromycin, tiamulin and salinomycin for about 
8 months before sampling. The concentrations of these four antibiotics in the sampled manure 
were below the limit of detection. 
 
2.3.1.2 Preparation of the degradation experiment  
30 Erlenmeyer flasks were filled with 100 g fresh manure that was spiked with a mixture of 
antibiotics at a concentration of 2,000 µg/kg to mimic excretion of treated animals. This 
concentration is based on the assumption that an administered dosage of 2 kg antibiotic is 
excreted completely by 800 pigs and that all of the liquid manure is stored in a 1,000 m3 
manure tank, which is the amount used by the local farmers [46]. 
The Erlenmeyer flasks were stored in the dark at 20°C (Memmert, Modell 800, Schabach, 
Germany) and closed with a fermenting tube in order to maintain anaerobic conditions. The 
loss of water during the experiment was compensated weekly by addition of HPLC-grade 
water after difference weighting. After a specified time period, the samples were 
homogenised, extracted and analysed. Three sub-samples of 15 g homogenised manure each 
were analysed. 
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2.3.2 Results of the manure degradation experiment 
2.3.2.1 Degradation experiment 
The concentrations (c) of erythromycin, roxithromycin, salinomycin and tiamulin during the 
degradation experiment are displayed in Figure 7a - Figure 10a. To obtain detailed insight, the 
data are shown on a natural log scale in Figure 7b - Figure 10b. Each point is the average of 
three replicate extractions of a single incubation. From these data, kinetic data such as half-
lives are calculated and presented in Table 20. 
 
Table 20: Slope of the linear regression, regression coefficient (R2) and half-life of 
macrolides, salinomycin and tiamulin during manure storage. 
 
 slope (k) R2 Half-life 
Erythromycin -0.017 0.98 41±1 days 
Roxithromycin -0.005 0.95 130±10 days 
Salinomycin -0.135 0.97 5.1±0.3 days 
Tiamulin - - >>200 days 
 
 
Erythromycin 
Erythromycin (Figure 7a) shows a typical first order degradation curve following equation (1) 
[54]:  
   
tkecc ⋅−⋅= 0        (1). 
The natural logarithm of the concentration divided by the starting concentration (c0) (ln c/c0) 
versus time (t) plot (Figure 7b) shows a straight line with a good regression (Table 20). Thus 
the degradation of erythromycin follows a first order degradation. From equation (2) a half-
life of 41 days was calculated for erythromycin in manure. 
 
   
k
2lnt
2
1 =         (2) 
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Figure 7: Concentration/time plot of erythromycin during an incubation of 16 single 
experiments in liquid manure (a) and plot of the natural logarithm of the 
concentration/starting concentration (c/c0) versus time of erythromycin (b) including the 95% 
confidence interval. Each point is the average of three extractions of one 100 g batch. Error 
bars are based on the standard deviation of the validated method. 
0 50 100 150 200
0
500
1000
1500
2000
2500
0 50 100 150 200
-5
-4
-3
-2
-1
0
1
C
on
ce
nt
ra
tio
n 
[µ
g/
kg
]
day day
(a) (b)
ln
(c
/c
) 0
 
 
Roxithromycin 
The kinetics of roxithromycin (Figure 8a) was similar to those of erythromycin, but had a 
slower elimination rate. From the natural logarithm of the c/c0 versus time plot (Figure 8b), a 
half-life of 130 days can be calculated by a kinetic expression.  
 
Figure 8: Concentration/time plot of roxithromycin during an incubation of 16 single 
experiments in liquid manure (a) and plot of the natural logarithm of the 
concentration/starting concentration (c/c0) versus time of roxithromycin (b) including the 95% 
confidence interval. Each point is the average of three extractions of one 100 g batch. Error 
bars are based on the standard deviation of the validated method. 
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Salinomycin 
The degradation kinetics of salinomycin (Figure 9a) is different to those of the macrolides. 
The concentration of salinomycin remained constant for about four days before significant 
elimination started. If the elimination was due to biodegradation, the microorganisms 
responsible for degradation needed a lag-phase to adapt to salinomycin before they were able 
to metabolise this compound. After 40 days, the concentration of salinomycin was below the 
limit of quantification of the analytical method. A first order degradation and a half-life of 5 
days could be calculated from the linear regression of the natural logarithm/time plot, starting 
from day four (Figure 9b). 
 
Figure 9: Concentration/time plot of salinomycin during an incubation of 16 single 
experiments in liquid manure (a) and plot of the natural logarithm of the 
concentration/starting concentration (c/c0) versus time of salinomycin (b) including the 95% 
confidence interval. Each point is the average of three extractions of one 100 g batch. Error 
bars are based on the standard deviation of the validated method. 
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Tiamulin 
The same experiment with tiamulin (Figure 10) gave completely different results. The 
concentration of tiamulin remained constant during the course of the entire experiment. No 
degradation was detectable even after 180 days. 
 
Figure 10: Concentration/time plot of tiamulin during an incubation of 16 single experiments 
in liquid manure (a) and plot of the natural logarithm of the concentration/starting 
concentration (c/c0) versus time of tiamulin (b) including the 95% confidence interval. Each 
point is the average of three extractions of one 100 g batch. Error bars are based on the 
standard deviation of the validated method. 
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Tests for higher order kinetics were applied to all four degradation plots, but no correlation 
could be found. Thus it is assumed that the first order kinetics is applicable. 
The standard deviation of the three replicates was in the same range or better as the standard 
deviation determined during the validation procedure for this analytical method. All point 
were within the 95% confidence intervals. The calculated half-lives and figures are based on 
the standard deviation of the validated method. 
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2.3.2.2 Determination of metabolites 
The extract from day 192, the extract of blank manure and a standard solution were measured 
in a full scan HPLC-MS run in ESI positive mode with the same HPLC conditions described 
above. For the sake of improved sensivity these experiments were performed on an API 2000 
(Applied Biosystems, Darmstadt). All chromatograms were compared with each other. Four 
new peaks were determined in the extract of day 192 (Figure 11) in comparison to the blank 
and standard solution. The same HPLC experiment with a high resolution mass spectrometer 
with electrospray ionisation in positive mode (Bio TOF III, Bruker, Bremen, Germany) 
resulted in high resolution mass spectras (HR-MS) of the chromatographic peaks at 19.7 min, 
20.1 min and 20.7 min. By means of ISOFORM Version 1.02 (NIST, United States) and the 
HR-MS data the empirical formula of all three peaks could be identified (Table 21).  
 
Figure 11: Full scan HPLC-ESI-MS run of the extract of day 192. Metabolites of 
salinomycin could be detected at 19.7 and 20.1 min and a metabolite of erythromycin at 14.8 
min. Residues of tiamulin (15.9 min) and roxithromycin (15.7 min) and a unknown compound 
at 20.7 min. 
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Metabolites of salinomycin 
Peak 19.7 min and 20.1 min were identified as two isomers of C29H48O7. The product ion scan 
(API 2000, Applied Biosystems, Darmstadt) of the ammonia adduct of C29H48O7 (Figure 12a) 
showed a similar spectrum as the product ion scan of the ammonia adduct of salinomycin 
(Figure 12b). It seems that the new formed metabolite resulted by a cleavage of salinomycin. 
Vértesy et al. described in their work a microbial decomposition product of salinomycin with 
the same empirical formula [55]. 
The peak at 20.7 could be identified by HR-MS as C29H46O7 (Table 21). The concentration of 
this metabolite was too small for further mass spectrometric experiments.  
 
Figure 12: Product ion scan of the ammonia adduct of the metabolite of salinomycin, 526 (a) 
and product ion scan of the ammonia adduct of salinomycin, 768 (b) 
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Metabolites of erythromycin 
By means of two MRM transitions, 716 --> 158 @ 45 eV, 716 --> 558 @ 25eV, and the same 
retention time of a standard solution, the peak at 14.8 was identified as anhydroerythromycin, 
a well known metabolite of erythromycin [56]. The synthesis of anhydroerythromcin has been 
described by McArdell et al. [57]. 
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Table 21: Measured mass of the three peaks at 19.7 min, 20.1 min and 20.7 min of a high 
resolution fullscan HPLC-ESI-TOF-MS run. Suggested elemental composition, theoretical 
mass for the suggested ion of the suggested composition and difference of the mass of the 
suggested elemental composition and measured mass in ppm. 
RT 
[min] 
Measured mass
[amu] 
Suggested 
elemental 
composition 
Theoretical 
mass for the 
suggested ion 
[amu] 
difference
[ppm] 
19.7 509.3466 [C29H48O7+H]
+ 509.3473 1.4 
 526.3726 [C29H48O7+NH4]
+ 526.3744 3.4 
 531.3286 [C29H48O7+Na]
+ 531.3292 1.1 
20.1 509.3482 [C29H48O7+H]
+ 509.3473 1.8 
 526.3729 [C29H48O7+NH4]
+ 526.3744 2.8 
 531.3293 [C29H48O7+Na]
+ 531.3292 0.2 
20.7 524.3586 [C29H46O7+NH4]
+ 
524.3488 1.9 
 529.3149 [C29H46O7+Na]
+ 529.3142 1.3 
 
 
2.3.3 Discussion to the manure degradation experiment 
Before manure is spread on fields, the manure is stored up to 180 days in tanks of the farmers 
in the region of North-Rhine-Westphalia, Germany. 
Erythromycin is used mostly as a one-time application in the beginning of the fattening phase 
of pigs. A one-time application means one application over 10-20 days during the lifetime of 
a pig for the treatment of an infection. With a half-life of 41 days, the excreted erythromycin 
is degraded up to 95 % during a 180 day storage in manure tanks. If the application of 
erythromycin is stopped a considerable time before the manure is applied to the fields, the 
contamination of the soil with high concentrations of this antibiotic can be prevented. Since 
the metabolite of erythromycin, anhydroerythromycin, has no antibiotic activity [56] a risk for 
the environment for this metabolite is probably lower than for the parent compound. 
 
Roxithromycin is currently not used as a veterinary antibiotic; however, it is used in human 
medicine. This leads to significant concentrations in wastewater [35]. This degradation 
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experiment with liquid manure may give some basic insight into the behaviour of 
roxithromycin in sewage treatment especially in the anaerobic processes in these plants, i.e. 
the digester.  
As a result of an incomplete elimination of roxithromycin in the digester, roxithromycin can 
enter the environment if digested sludge is used as fertiliser on agricultural fields. 
 
Salinomycin shows a rapid degradation with a half-life of 5 days in this manure; therefore, the 
application of salinomycin might be considered to be less problematic. However, salinomycin 
is used as a feed additive for the prevention of the coccidiosis and for growth promotion. 
Growth promoting is the continuous application of the antibiotic to promote weight gain in 
the fattening phase of pigs. In both cases, a continuous flow of freshly excreted salinomycin 
comes from the stables to the manure tank. A 99 % degradation of salinomycin in the manure 
tanks requires about 38 days. Thus there is not enough time for the complete degradation of 
salinomycin, the soil may be contaminated with salinomycin if this manure is dispersed on the 
fields. The newly formed metabolite of salinomycin has, according to Vértesy et al. [55], no 
antibiotic activity and is no longer capable to complexing sodium or potassium. However, 
there is no full risk evaluation for this compound yet. 
 
In contrast, tiamulin showed no degradation. When manure containing tiamulin is spread on 
the fields, the soil will be contaminated. These conclusions correspond with other studies [58] 
where tiamulin and salinomycin were detected two months after the application in liquid 
manure at concentrations of 11 µg/kg and 43 µg/kg, respectively. Also, tiamulin was detected 
in soil which was fertilised with manure that contained tiamulin a considerable time before 
sampling [59]. 
Haller et al. [60] and Tolls [44] have demonstrated that the antibiotics tylosin, sulfonamides 
and tetracyclines are persistent in soil and manure as well. Gavalchin and Katz  reported the 
half-life of chlortetracycline of above 30 days and tylosin of 5 days in a manure soil matrix 
under aerobic conditions at 20 °C [61]. Also Hamscher et al. and Pfeifer et al. found high 
concentrations of tetracyclines and sulfonamides in liquid manure several months after 
application to pigs [41, 51]. 
From the data presented here, it seems that the use of some macrolides and polyether 
antibiotics would be preferable to sulfonamides and tetracyclines, while tiamulin should be 
avoided, if environmental aspects are taken into account. 
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2.3.4 Conclusions to antibiotics in manure 
A precise and rapid multimethod with low LOQ has been developed to analyse macrolides, 
ionophores and tiamulin in manure. Liquid-liquid extraction followed by a diol SPE clean-up 
step resulted in sufficient clean extracts, which were analysed by HPLC-APCI+-MS/MS. 
Recoveries for the macrolides ranged from 75 – 94 %, for the ionophore salinomycin the 
recovery rate was 119 %, while the pleuromutilin tiamulin has a recovery rate of 123 %, i.e. 
salinomycin and tiamulin are not significantly higher than 100 %. Recoveries were not 
dependent on the concentration level. No blank problems were detected during the method 
validation and the applications. The limit of detection ranged from 0.4-3.3 µg/kg, and LOQs 
ranged from 1.4-11.0 µg/kg. In the tested samples tiamulin was found at concentrations of 43 
µg/kg manure and salinomycin at concentrations of 11 µg/kg. This method is more sensitive 
that of Hamscher et al. who investigated tetracycline antibiotics in manure [41]. 
The degradation experiment showed that tiamulin, which is a pleuromutilin compound, is 
persistent in manure. Additionally, it was shown that macrolides, as well as the polyether 
antibiotic salinomycin, are degraded under the conditions prevalent in manure tanks. 
Metabolites of salinomycin and erythromycin were detected in this experiment and a new 
metabolite was found. However, some questions about the persistence of these metabolites 
remain, as well as more basic discussions on the usage of antibiotics in industrial agriculture. 
As tiamulin is very persistent in manure, its use should be avoided if environmental issues are 
taken in consideration.  
Further degradation experiments of other antibiotics such as sulfonamides and tetracyclines in 
liquid manure under anaerobic conditions are necessary to create guidelines for farmers that 
will give sufficient time between termination of antibiotic use in their livestock and manure 
spreading.  
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3 Occurrence and fate of antibiotics in soil 
3.1 Introduction to antibiotics in soil 
The continuation of the veterinary route of pharmaceutical in the environment (Figure 1, path 
B) is the sink of antibiotics in soil [41, 43, 58, 60]. Large fractions of veterinary used 
antibiotics are transferred to manure tanks after application. Antibiotics which are applied to 
humans are transferred through the sewers to sewage treatment plants after excretion. The 
antibiotics may adsorb to the sewage sludge or leave the treatment plant unchanged with the 
STP discharge water [34, 35]. Manure and sewage sludge are dispersed on the fields and the 
antibiotics may contaminate the soil and eventually the ground water [62, 63, 64, 65]. After 
fertilising the fields with manure or sewage sludge which contains antibiotics, these 
compounds may undergo several processes resulting in complete or partial elimination of the 
parent compound [66]. Three different degradation behaviours are discussed:  
1) Complete elimination through mineralisation of the antibiotics. 
2) Partial transformation and  
3) Persistence of the compounds in the environment. 
This study describes the decrease of the antibiotics with an aerobic degradation experiment in 
soil during a 120-day time period. A reliable method to determine the more recently used 
antibiotics with macrocyclic, polyether or pleuromutilin structures has not been described in 
the open literature yet. However, some tetracyclines have been analysed by Hamscher et al. 
[41, 67]. Before the degradation experiment could be performed, a method for the 
determination of these antibiotics in soil must be developed. As soil is a complex matrix, an 
exhaustive extraction is important to obtain high recovery rates and an efficient clean-up 
procedure is necessary to remove interfering matrix components. 
Compounds of interest are the macrolide antibiotics erythromycin and oleandomycin, which 
are used in human and veterinary medicine, roxithromycin, which is used only for human 
applications, and tylosin, a veterinary drug. The pleuromutilin derivative tiamulin, a 
veterinary antibiotic and the ionophore salinomycin, which is used for growth promoting in 
animal husbandry are studied as well. In this study the term degradation is used to describe 
decrease of concentration of the respective parent compound. 
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3.2 Method development and validation to antibiotics in 
soil 
3.2.1 Experimental to antibiotics in soil 
3.2.1.1 Chemicals to antibiotics in soil 
Acetonitrile (HPLC-S gradient grade) was purchased from Biosolv (Valkenswaard, 
Netherlands). Water (HPLC grade) was obtained from Mallinckrodt Baker (Griesheim, 
Germany). Methanol (suprasolv grade) and acetone (analytical grade) were obtained from 
Merck (Darmstadt, Germany). 
Ammonium acetate, aqueous ammonia solution (25 %) and glacial acetic acid were of 
analytical grade and were purchased from Merck. Erythromycin, tylosintartrate and 
roxithromycin were provided by Sigma-Aldrich (Seelze, Germany). Salinomycin SV sodium 
salt 2.5-hydrate, oleandomycin phosphate dihydrate and tiamulin fumarate (VetranalTM) were 
obtained from Riedel-de Haën (Seelze, Germany). The synthesis of (E)-9-[O-(2-
methyloxime)]-erythromycin is described by Schlüsener et al. [58] and described above in 
chapter 2.2.1.2. 
 
 
3.2.1.2 Soil 
A typical German sandy loam soil (Monheim, Laacher Hof, AXXa, provided by Bayer Crop 
Protection, Leverkusen, Germany), which fulfils the requirements for standard pesticide 
registration studies, was taken from the surface layer (0-10 cm) in areas with vegetation for 
the degradation experiments. It had not received any antibiotic applications for at least 7 
years. The soil was stored after sampling for one year maximum in a greenhouse with grass 
on the surface area and watered in regular intervals before the start of this study. Table 22 
shows the complete physicochemical properties of the used soil. 
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Table 22: Physicochemical properties of the soil, taken from Monkiedje et al. [68]. 
Texture analysis (USDA)  
clay (<2µm) (%) 5 
silt (<50-2µm) (%) 23 
sand (2000-50µm) (%) 72 
pH (water, ratio 1:2.5) 7.20 
pH (0.01 M CaCl2, ratio 1:2.5) 6.75 
Corg. (%) 1.69 
Norg. (%) 0.09 
P (mg P2O5/100 g dry weight) 57.0 
cation exchange capacity  
(mequiv/100 g dry weight) 8.0 
maximum water holding capacity 34.4 
density (g/ml) 2.5 
 
3.2.1.3 Accelerated Solvent Extraction (ASE) 
Humid soil samples which were taken from fields were stored at –20 °C prior to extraction. 
After defrosting 30 g of sieved (2 mm) humid soil were transferred into a 33 mL ASE 
extraction cell. Soils from the degradation experiment and for the method validation were 
filled directly into the cells. The cell was subsequently filled with Ottawa sand (20-30 mesh, 
Fischer Scientific, Schwerte, Germany) to reduce the void volume. The cells were sealed at 
both ends with circular cellulose filters (REF NO.: 321432, Schleicher & Schüll, Dassel, 
Germany) and end caps were fitted. 
The ASE cells were extracted with aqueous ammonia in methanol (1% v/v) with following 
ASE conditions: preheat: 0 min; static: 10 min; flush: 70 %; purge: 180 sec; cycles: 2; 
pressure: 140 bar; temperature: 80 °C. After the extraction 25 µL of internal standard solution 
(10 mg (E)-9-[-O-(2-methyloxime)]- erythromycin in 100 mL acetonitrile), followed by 
150 µL of glacial acetic acid were added to the extract and the flask was shaken by hand for 
10 seconds. The mixture was poured in a 100 mL distilling flask and the sample volume was 
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reduced to 5 mL using a rotary evaporator at 60 °C and 290 mbar. The residue was dissolved 
in 15 mL water and the volume was reduced again to 10 mL at 60 °C and 150 mbar.  
 
3.2.1.4 SPE clean-up to antibiotics in soil 
Diol solid-phase extraction cartridges from UCT (2000 mg, Bristol PA, United States) were 
conditioned with 10 mL methanol followed by 10 mL water. A solid-phase extraction 
manifold (IST, Grenzach-Wyhlen, Germany) with PTFE stopcock and outlet was used. The 
soil extract (10 mL) was passed through the cartridge at a speed of 5 mL/min (vacuum). The 
cartridge was washed with 10 mL water to remove interfering matrix components, e.g. salts 
and co eluting matrix components. The SPE cartridges were eluted twice with 4 mL of an 
acetonitrile : 0.1 M aqueous ammonium acetate (3:2, v/v) mixture. An aliquot of 0.8 mL of 
the eluate was transferred to a 1.5-mL autosampler vial for HPLC-MS/MS analysis. Figure 13 
shows the complete procedure for analysis of antibiotics in soil. 
 
Figure 13: Sample preparation for soil 
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3.2.1.5 HPLC to antibiotics in soil 
Separations were performed using a Phenosphere-Next RP18 column (2 mm i.d., length 150 
mm, particle size 3 µm) and a SecurityGuard (Phenomenex, Torrance CA, United States) at 
25 ± 1 °C. The flow rate was 0.2 mL/min. The HPLC gradient was established by mixing two 
mobile phases: phase A: 10 mM aqueous ammonium acetate solution and phase B: pure 
acetonitrile. Chromatographic separation was achieved with the following gradient: 0-1 min: 
10% B, 1 min ->14 min: 10% -> 100% B, 14-29 min: 100% B, 29 min -> 30 min: 100% -> 
10% B, 30-35 min: 10% B. Ten µL of each sample was injected. 
The HPLC system consisted of a GINA 50 autosampler, a P 580A HPG HPLC pump, a 
degasser unit DEGASYS DG-1210 and a column oven STG 585 (all from Dionex, Idstein, 
Germany). The dead time of the HPLC system was 1.8 min. After HPLC separation, the 
analytes were determined by atmospheric pressure chemical ionisation / tandem mass 
spectrometry (APCI+-MS/MS) in positive ion mode and selected reaction monitoring (SRM). 
 
3.2.1.6 Mass spectrometry to antibiotics in soil 
The triple quadrupole mass spectrometer (TSQ 7000, Finnigan-MAT, Bremen, Germany) was 
equipped with an APCI 2 source and operated under the following conditions: capillary 
temperature, 180 °C; sheath gas, 40 psi; corona current, 5 µA; vaporizer temperature, 450 °C; 
auxiliary gas, off; q0 offset, -4.4 V; collision cell pressure, 2.0 mTorr; collision gas, argon; 
multiplier, 1900 V. The potential difference between the capillary and the tube lens was held 
at 70 V. The cycle time was 1.0 s during the chromatographic determination of the antibiotics. 
The data were processed using XcaliburTM 1.3 software (Thermo Electron Corporation, West 
Palm Beach FL, United States). The silica capillary of the APCI 2 source was replaced by a 
steel capillary in order to reduce tailing of antibiotics adsorbing on the silica surface [49]. 
APCI was preferred because this ionisation is less vulnerable to matrix effects than ESI [50, 
51]. 
A post-column Valco divert valve was used to direct most of the non-significant LC flow of a 
sample to waste. Diverting the flow minimised contamination of the MS source: 0-8 min 
divert to waste, 8-28 min flow to mass spectrometer, 28-35 min divert to waste. An additional 
flow of 50 µL/min water acetonitrile (3:7, v/v) pumped by a LC-10 AT HPLC (Shimadzu, 
Duisburg, Germany) compensated the missing flow from the HPLC during waste positing 
operation. Automatic data acquisition was triggered using a short contact closure signal of the 
autosampler. 
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To gain higher selectivity, selected reaction monitoring (SRM) was chosen. Key parameter 
settings for SRM are given in Table 23. 
 
Table 23: Retention times as well as MS-conditions for the analysis of macrolides, 
salinomycin and tiamulin in soil 
 
Retention 
time 
Precursor-Ion Product-Ion 
Collison-
energy 
Erythromycin 11.4 min 734.5 576.5 -22 eV 
Roxithromycin 12.9 min 837.5 679.5 -25 eV 
Salinomycin 24.1 min 768.7 733.6 -22 eV 
Tiamulin 13.6 min 496.6 192.3 -27 eV 
Oleandomycin 11.2 min 688.5 544.5 -20 eV 
Tylosin 12.1 min 917.1 772.5 -32 eV 
 
 
3.2.1.7 Calibration to antibiotics in soil 
The calibration was performed as an internal standard calibration in the presence of soil 
matrix to overcome matrix effects [50, 51]. A typical German soil (Monheim, Laacher Hof, 
AXXa) was chosen for preparation of the standards in the presence of soil matrix for HPLC-
MS/MS determination.  
A stock solution was produced by dissolving 10 mg of the macrolides, ionophores and 
tiamulin in 100 mL acetonitrile. This standard solution was stored at 4 °C in the dark and was 
stable at least for 3 months. Calibration standards (5, 10, 50, 100, 500, 1,000 and 
5,000 ng/mL) were made by serial dilution of the stock solution. The IS was added to the 
calibration standards in an amount of 500 ng/mL. The respective calibration standard solution 
(0.5 mL) was filled in 1.8-mL HPLC vials and 0.5 mL soil matrix was added. The soil matrix 
solution was produced by extracting ‘AXXa’ soil by ASE with successive SPE cleanup as 
described above. The calibration curves were calculated using a weighted (1/X) linear 
regression model. 
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3.2.1.8 Recovery experiments to antibiotics in soil 
For validation of the method, 100 g of antibiotic-free soil from Laacher Hof were spiked with 
the stock solution (1; 6; 20; 200 and 2,000 µg/kg soil) using the following protocol: 
To avoid potential effects of solvents upon the sorption of compounds to the soil, the volumes 
of the application solution (1-1,800 µL) were deposited evenly onto portions of ~10 g air-dry 
soil in porcelain dishes. Such treated samples of soils were thoroughly mixed with a spatula 
until the solvent was completely evaporated ( ~10 min) and the respective compounds were 
evenly distributed. The respective 10 g samples were subsequently added to the total soil 
mass of the corresponding soil (100 g). These 110 g soil samples were homogenised by means 
of a tumbling mixer for one hour. They were extracted within an hour after homogenisation. 
Control experiments after 24 h aging of the spiked soil gave the same recovery rates with this 
method. 
Recovery experiments for the macrolides, ionophores and tiamulin were carried out at five 
concentration levels in triplicate.  
 
3.2.2 Results and discussion to antibiotics in soil 
All analytes were completely separated by HPLC. The calibration graphs show linearity in the 
range from the limit of quantitation (LOQ) up to 5,000 ng/mL with regression coefficients 
(R2) better than 0.992.  
 
3.2.2.1 Results of temperature and solvent optimisation of the ASE 
For the optimisation of the ASE conditions, samples of 10 g soil were each spiked with 50 µL 
stock solution (10 mg of macrolides, ionophores and tiamulin in 100 mL acetonitrile) and 
placed in an 11 mL ASE extraction cell. These samples were extracted three times into 
separate vials in four different experiments using acetone, acetonitrile, methanol and 1% (v/v) 
aqueous ammonia in methanol at temperatures varied from 40 to 120 °C in 10 ° steps (Fig. 3). 
These extracts were analysed directly after centrifugation (C-1200, NeoLab, Heidelberg, 
Germany) by HPLC-MS/MS. During this ASE optimisation experiment, all three extracts 
were analysed separately. Significant amounts of analytes were found in the second extract 
but no analytes were found in the third. In Figure 14 the results of the first and second 
extraction of roxithromycin as a function of temperature are summarised. The other analytes 
behave similarly. For all compounds, optimum extraction efficiency was found at 80°C and 
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140 bar. Above 80 °C the analytes may be hydrolysed. Temperature and pH value may help to 
dissolve the analytes from humic acids and other soil matrix compounds. Increasing the static 
extraction time from 10 min up to 20 min did not result in higher recovery rates. To get a 
more homogenous soil sample 33 mL extraction cells with 30 g sample were chosen for 
validation and the recovery study. 
 
Figure 14: Extraction of roxithromycin in spiked soil samples with different solvents at 
various temperatures. The graph shows the relative extraction performance (Area ratio = Area 
roxithromycin/Area internal standard) depending on the temperature and the solvent. 
This optimisation of the ASE conditions shows the best extraction performance with 
methanol: aqueous ammonia (1 % v/v) at 80 °C and 140 bar. 
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3.2.2.2 Results of the recovery study 
The recovery rates of roxithromycin and tiamulin as selected samples are shown in Figure 15. 
Recovery rates of all experiments were averaged (Table 24) since there was no concentration 
(1, 6, 20, 200 and 2,000 µg/kg) dependency of recoveries. For the macrolides mean recoveries 
of 32% (RSD 23 %) to 93 % (RSD 20 %) were obtained. Salinomycin was found with 74 % 
(RSD 29 %) and tiamulin with 118 % (RSD 19 %). The limit of detection (LOD) was taken as 
a signal-to-noise ratio (S/N) of 3:1 and the limit of quantitation (LOQ) was defined as a 
signal-to-noise ratio of 10:1 (Table 24). No blank problems were detected during the method 
validation and the applications. 
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Figure 15: Recovery for roxithromycin (a) and tiamulin (b) at five concentration levels (1; 6; 
20; 200 and 2,000 µg/kg soil). The standard deviation (SD) for three replicates is indicated by 
an error bar, the standard deviation of the validated method is indicated by a dashed line. 
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Table 24: Mean recovery, relative standard deviation (RSD) and limit of quantification 
(LOQ) (three extractions, repetitions for each concentration level) of macrolides, ionophores 
and tiamulin in soil. Recoveries were determined at concentrations of 1; 6; 20; 200 and 2,000 
µg/kg manure. LOQ: S/N = 10:1 
 
Recovery rate 
[%] 
RSD  
[%] 
LOQ  
[µg/kg] 
Erythromycin 43 23 1.4 
Roxithromycin 94 19 1.0 
Salinomycin 76 32 5.3 
Tiamulin 118 18 0.6 
Oleandomycin 38 51 1.4 
Tylosin 32 23 30 
 
The recovery rates of roxithromycin, tiamulin and salinomycin were in an acceptable 
analytical range. The recovery rates of oleandomycin, erythromycin and tylosin were 
generally too low, but no analytical method has been described in the open literature yet for 
soil with better results. The low recovery rates based on an sorption of the antibiotics to soil 
compounds. Especially tylosin builds complexes with calcium, which resulted in 
unextractable material. However, the recovery rates were sufficient enough for a degradation 
experiment in soil, because the recovery is constant over the working range of the degradation 
experiment. 
3.2.2.3 Comparison to field data 
The validated method was tested for several samples of two fields, in order to investigate the 
persistence of antibiotics in manure fertilised soil samples. Figure 16 shows the sampling 
procedure of two fields. Field I was only fertilised in February 2001 and field II was fertilised 
in August 2001 and February 2002 with liquid manure, which contained tiamulin (43 µg/kg) 
and salinomycin (11 µg/kg) [58]. Additionally the amount of applied manure was given (20 
m³/ha). 
The samples were taken in November 2001 (white spots with Arabic numbers 1-12) and in 
May 2002 (yellow spots with letters A-I) from the first 30 cm of the surface layer. 
Additionally sample C and D were divided into two portions of 0-15 cm and 15-30 cm. The 
samples were stored at -20 °C prior extraction. Table 25 illustrates the concentration of 
tiamulin in these soil samples. Neither salinomycin, nor any other of the analysed antibiotics 
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were detected, though salinomycin was applied at the respective farm. Figure 17 shows the 
SRM trace of a soil sample extract, which contained tiamulin. The concentration ranged from 
0.9 µg/kg up to 1.9 µg/kg soil. 
From these data it can be shown that tiamulin persists in the soil. Even one year after 
fertilising the field with contaminated manure the concentration of tiamulin remains constant 
(Field I). The upper surface layer (0-15 cm) is more contaminated with tiamulin and the 
concentration was raising when the fields were fertilised again and again (Field II) with 
manure which contains tiamulin. 
 
Figure 16: Sketch of the sampling of two fields. Samples were taken in November 2001 
(spots 1-12) and in May 2002 (spots A-I) from the first 30 cm of the surface layer. 
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Figure 17: APCI SRM trace of a soil sample which contains tiamulin (0.9 µg/kg). The soil 
was fertilised with manure, which contained tiamulin (43 µg/kg), 9 months before sampling. 
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Table 25: Concentrations of tiamulin in soil. Field I was fertilised in February 2001 and field 
II was fertilised with liquid manure, which contained 43 µg/kg tiamulin, in August 2001 and 
February 2002. 
 
 November 2001 May 2002 
 Sampling point Tiamulin [µg/kg] Sampling point
Tiamulin 
[µg/kg] 
(1) 1.9 (A) 2.2 
(2) 1.2 (B) 1.5 
(C, 0-15 cm) 1.1 
(3) 1.0 
(C, 15-30 cm) 0.5* 
(D, 0-15 cm) 1.1 
(4) 1.4 
(D, 15-30cm) 0.6* 
(5) 1.4 (E) 1.3 
(6) 0.5 (F) 1.7 
Fi
el
d 
I 
Mean 1.2 Mean 1.7 
(7) 0.9 (G) 1.1 
(8) 0.5* (H) 1.1 
(9) 0.5*   
(10) 0.5*   
(11) 0.4*   
(12) <LOD (I) 3.3 
Fi
el
d 
II
 
Mean 0.5 Mean 1.4 
 *:<LOQ 
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From theoretical considerations a concentration of tiamulin in soil was predicted: 
The PECsoil was calculated with the following assumptions and formula (3): 
density manure (ρmanure) : 1,000 kg/m3 
concentration of antibiotics in the manure (bantibiotic): 43 µg/kg [58] 
area based load of manure (QN): 20 m3/ha 
density soil(ρsoil): 1,800 kg/m3 
penetration depth of the antibiotics in soil (Hdepth): 15 cm 
depth
2
soil
Nantibioticmanure
soil Hm10000
Qb
PEC ⋅⋅
⋅⋅= ρ
ρ
      (3) [58] 
The concentration of tiamulin (0.9 µg/kg) was higher than the predicted environmental 
concentration (PECsoil) of 0.3 µg/kg soil [53]. This is different to Kümmerer’s own improved 
data of (PECsoil) 3-180 µg/kg soil [69]. Thus the concentrations in the field are slightly higher 
than predicted by Monforts, but considerably lower than predicted by Kümmerer [53, 69]. 
Possibly the concentration of tiamulin in the applied manure was higher than 43 µg/kg. 
Further experiments, like time- and temperature-dependent degradation experiments are 
necessary to obtain more information about the long-term stability of these compounds in soil. 
3.3 Soil degradation experiment 
3.3.1 Experimental to the soil degradation experiment 
Chemicals, sample pre-treatment, ASE extraction, SPE clean-up, HPLC and mass 
spectrometry conditions were the same as described above. The same soil for the degradation 
experiment as for method development and matrix calibration was used (Table 22). 
3.3.1.1 Degradation experiment  
20 Erlenmeyer flasks were filled with 110 g sieved (2 mm) humid soil that was spiked with a 
mixture of antibiotics at a concentration of 2,000 µg/kg using the following protocol: 
To avoid potential effects of solvents (acetonitrile) upon the sorption of compounds to the 
soil, the volumes of the application solution (1,800 µL) were deposited evenly onto portions 
of ~10 g air-dry soil in porcelain dishes. The thus treated samples of soils were thoroughly 
mixed with a spatula until the solvent was completely evaporated (~10 min) and the 
respective compounds were evenly distributed. The respective 10 g samples were 
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subsequently added to the total soil mass of the corresponding soil (100 g). These 110 g soil 
samples were homogenised by means of a tumbling mixer for one hour. 
The Erlenmeyer flasks were stored in the dark at 20°C (Memmert, Modell 800, Schabach, 
Germany) and stoppered with glass wool to reduce water evaporation. The soil water content 
was about 12% (w/w). The loss of water during the experiment was compensated weekly with 
HPLC-water (Mallinckrodt Baker, Griesheim, Germany) by difference weighting. At 15 
sampling times single flasks were analysed (t = 0, 1, 3, 5, 7, 12, 15, 19, 22, 28, 34, 42, 62, 85, 
115 days). 
Before the extraction started, the soil was mixed by shaking the Erlenmeyer flask for 1 min by 
hand. 30 g of soil were transferred into a 33 mL ASE (ASE 200, Dionex, Idstein, Germany) 
extraction cell. Three sub-samples of 30 g mixed soil from each sampling day were analysed. 
3.3.2 Results and discussion to the soil degradation experiment 
The concentrations (c) of erythromycin, roxithromycin, salinomycin, tiamulin, oleandomycin 
and tylosin during the degradation experiment are displayed in Figure 18a - Figure 23a. To 
obtain detailed insight, the data are shown on a natural log scale in Figure 18b - Figure 23b. 
Each point is the mean of three replicate extractions of a single incubation. From these data, 
kinetic data such as half-lives are calculated and presented in Table 26. Tests for higher order 
kinetics as first order were applied to all degradation plots, but no correlation could be fitted.  
The standard deviation of the three replicates was in the same range or better as the standard 
deviation determined during the validation procedure for this analytical method. The 
calculated half-lives and figures are based on the standard deviation of the validated method. 
 
Table 26: Slope of the linear regression, regression coefficient (R2), half-life of macrolides, 
salinomycin and tiamulin 
 slope (k) R
2 Half-life 
Erythromycin -0.035 0.96 20±1.2 days 
Roxithromycin - - >>120 days 
Oleandomycin -0.031 0.91 27±2.5 days 
Tylosin -0.086 0.98 8.3±0.4 days 
Salinomycin -0.133 0.95 5.0±0.5 days 
Tiamulin -0.027 0.98 16±0.8 days 
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3.3.2.1 Erythromycin 
Erythromycin (Figure 18) shows a typical first order degradation curve following equation (1) 
[54].  
   
tk
0 ecc
⋅−⋅=        (1) 
The natural logarithm of the concentration divided by the starting concentration (c0) (ln c/c0) 
versus time (t) plot shows a straight line with a regression coefficient of 0.96 (Table 26). All 
data points are within the 95 % confidence interval except day 62. This point was considerd to 
be an outlier and it was excluded for the calculation of the half-life. Thus the degradation of 
erythromycin follows a first order degradation. From equation (2) a half-life of 20 days was 
calculated for erythromycin in soil. 
   k
2lnt
2
1 =         (2) 
The result of this degradation experiment corresponds with results of Gavalchin and Katz 
[61], who investigated the degradation of erythromycin in a soil-faeces matrix via bioassay. 
This experiment does not have any implications for agriculture, but it is the only experiment, 
reported in the literature that is at least similar. These authors calculated a half-life of 12 days 
for this compound at 20 °C. 
 
Figure 18: Concentration/time plot of erythromycin during an incubation of 15 single 
experiments in soil during an incubation of 15 single experiments in soil (a) and plots of the 
natural logarithm of the concentration/starting concentration (c/c0) versus time of 
erythromycin including the 95 % confidence interval. Each point is the average of three 
extractions of one 110 g batch. 
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3.3.2.2 Roxithromycin 
The same experiment with roxithromycin (Figure 19) produced completely different results. 
Only a slight decrease of the concentration was detectable even after 120 days. It was not 
possible to calculate a half-life. 
If soil is fertilised with sewage sludge which may contain this antibiotic, the soil will be 
contaminated with roxithromycin and the compound may persist in the environment. 
 
 
Figure 19: Concentration/time plot of roxithromycin during an incubation of 15 single 
experiments in soil during an incubation of 15 single experiments in soil (a) and plots of the 
natural logarithm of the concentration/starting concentration (c/c0) versus time of 
roxithromycin including the 95 % confidence interval. Each point is the average of three 
extractions of one 110 g batch 
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3.3.2.3 Salinomycin 
The degradation of salinomycin (Figure 20) is faster than the degradation of erythromycin. 
After day 36, the concentration of salinomycin was below the limit of quantification of the 
analytical method. A first order degradation and half-life of 5 days was calculated from the 
linear regression of the natural logarithm/time plot. 
With this short half-life in soil salinomycin should cause less problems in soil than 
sulfonamides and tetracyclines. However, an effect on soil microorganisms cannot be 
excluded. 
 
 
Figure 20: Concentration/time plot of salinomycin during an incubation of 15 single 
experiments in soil during an incubation of 15 single experiments in soil (a) and plots of the 
natural logarithm of the concentration/starting concentration (c/c0) versus time of salinomycin 
including the 95 % confidence interval. Each point is the average of three extractions of one 
110 g batch 
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3.3.2.4 Tiamulin 
Tiamulin (Figure 21) shows a typical first order degradation curve until day 62. After this day 
the concentration of tiamulin in soil seems to be constant. The natural logarithm of the 
concentration (c) divided by the starting concentration (c0) (ln c/c0) versus time (t) plot shows 
a straight line from day 0 to day 62. Therefore the degradation of tiamulin follows a first order 
degradation up to day 62. A half-life of 16 days was calculated for tiamulin in soil. 
Further experiments have shown that tiamulin is present in liquid manure when the farmer 
used tiamulin to treat or prevent infections in their livestock [58]. After storing manure for 
about 180 days in manure tanks, tiamulin is still present in manure and shows no degradation 
[70]. The soil will be contaminated with tiamulin if this manure is used as fertiliser. 
With a half-life of 16 days till day 62 and no degradation afterwards tiamulin persist for a 
long time in small concentrations after fertilising the field. This is in accordance with results 
from field sampling, Table 25 and [59]. 
 
 
Figure 21: Concentration/time plot of tiamulin during an incubation of 15 single experiments 
in soil during an incubation of 15 single experiments in soil (a) and plots of the natural 
logarithm of the concentration/starting concentration (c/c0) versus time of tiamulin including 
the 95 % confidence interval. Each point is the average of three extractions of one 110 g batch 
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3.3.2.5 Oleandomycin 
Oleandomycin (Figure 22) shows a typical first order degradation curve. A half-life of 27 
days was calculated for oleandomycin from natural logarithm of the concentration divided by 
the starting concentration (c0) (ln c/c0) versus time (t) plot. 
This antibiotic is more stable in soil than tylosin or erythromycin. 
 
 
Figure 22: Concentration/time plot of oleandomycin during an incubation of 15 single 
experiments in soil during an incubation of 15 single experiments in soil (a) and plots of the 
natural logarithm of the concentration/starting concentration (c/c0) versus time of 
oleandomycin including the 95 % confidence interval. Each point is the average of three 
extractions of one 110 g batch 
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3.3.2.6 Tylosin 
Tylosin (Figure 23) shows typical first order degradation curve. A half-life of 8 days was 
calculated for tylosin from natural logarithm of the concentration divided by the starting 
concentration (c0) (ln c/c0) versus time (t) plot.  
Also Gavalchin and Katz found a rapid degradation of tylosin in a soil-faeces matrix at 20 °C. 
A half-life of 4-8 days was determined by Ingerslev et al. for tylosin in a soil-manure slurry 
[71].These experiment does not have any implications for agriculture, but these are the only 
experiments, reported in the literature that are at least similar. 
 
 
Figure 23: Concentration/time plot of tylosin during an incubation of 15 single experiments 
in soil during an incubation of 15 single experiments in soil (a) and plots of the natural 
logarithm of the concentration/starting concentration (c/c0) versus time of tylosin including 
the 95 % confidence interval. Each point is the average of three extractions of one 110 g 
batch. 
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3.3.3 Conclusions to antibiotics in soil 
In the past, it has been demonstrated that antibiotics such as tylosin, sulfonamides, 
virginiamycin and tetracyclines are persistent in soil [41, 72, 73]. In this study it was 
demonstrated that indeed roxithromycin, which is a semi synthetic macrolide, is persistent in 
soil as well, while tiamulin is persistent at low concentrations. 
Additionally it was demonstrated that erythromycin, oleandomycin, tylosin as well as the 
polyether antibiotic salinomycin, are degraded under conditions prevalent on fields. However, 
some questions about the persistence of metabolites remain. From the data presented in this 
study, it seems that the application of tylosin, erythromycin and polyether antibiotics might 
have less impact on soil than sulfonamides and tetracyclines. As roxithromycin is very 
persistent, fertilising the soil with sewage sludge should be avoided if environmental issues 
are taken in consideration. However, the longer a given antibiotic persists in the soil in an 
active form, the greater the potential for the bacterial populations of the soil to be affected, 
especially to become resistant. Effects on ground water or surface runoff water can not be 
excluded. 
Also a rugged and rapid multiresidue method with low LOQ has been developed to analyse 
macrolides, ionophores and tiamulin in soil. ASE extraction followed by a diol SPE clean-up 
step resulted in sufficient clean extracts, which were analysed by HPLC-APCI+-MS/MS. The 
LOQs that were obtained in this study are lower than those published by Hamscher et al. [41] 
who investigated tetracycline antibiotics in manure and soil. 
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4 Occurrence and fate of hormones and antibiotics 
in wastewater. 
4.1 Determination and method validation of steroid 
hormones, hormone conjugates and macrolide 
antibiotics in influents and effluents of sewage 
treatment plants. 
4.1.1 Introduction to the method validation of hormones and 
antibiotics in wastewater 
The occurrence of endocrine disrupting chemicals as well as antibiotics in the environment 
has become an important issue in the last decades [74]. Especially steroid hormones and 
contraceptives are of special concern due to their endocrine potency [75]. The natural sex 
hormone estradiol, which has a high endocrine potential, its metabolites (estrone and estriol) 
and conjugates (glucuronides and sulfates) are mainly excreted by mammals [56]. Also the 
synthetic contraceptives ethinylestradiol and mestranol have high a endocrine potential and 
are excreted by women medicated by these drugs. Feminisation of fish living near the 
effluents of sewage treatment plants has been observed [76, 77]. Estrogenic effects on fish 
have been observed down to 1 ng/L in laboratory studies [78]. 
Antibiotics are also excreted by medicated humans and they have the potential to build 
resistant bacteria stems. Neu reported 1992 the resistance of bacteria to the majority of 
existing antibiotics [10]. These compounds are transferred through the sewers to sewage 
treatment plants and enter the environment through the effluent of the respective plants. Also 
an inhibition of the aerobic growth and inhibition of the nitrification of bateria in sewage 
sludge by antibacterial agents has been reported by Halling-Sørensen [79]. 
Several methods have been described in the literature to quantify steroid hormones in STP 
effluents. They are mostly based on solid phase extraction, derivatisation of the analytes and 
detection by GC-MS [80, 81]. The limits of quantification (LOQ) for such methods are in the 
range of low nanograms-per-liter. The determination of the estrogens in unfiltered STP 
influents needs a sufficient clean-up step to remove interfering matrix components [82]. 
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Hormone-conjugates cannot be determined directly by GC-MS. These analytes must be 
enzymatically decomposed to gain the free estrogens prior to derivatisation and successive 
analysis by GC-MS [83 ,84 ,85]. On the other hand the conjugates can be determined directly 
by using liquid chromatography coupled with tandem mass spectrometry instead of GC-MS.  
A method for the determination of roxithromycin, and clarithromycin as well as 
anhydroerythromycin, a transformation product of erythromycin without antibiotic activity 
[56], in effluents of sewage treatment plants has been reported by Göbel et al. and Hirsch et 
al. [15, 35]. In these studies erythromycin was transformed to anhydroerythromycin by using 
acidic conditions, thus it remains unclear whether the samples contained the parent or the 
transformation product. 
The aim of this study was to develop a reproducible, robust and sensitive multiresidue method 
based on the recommendation of Green [86] to investigate the fate of estrone (E1), 17β-
estradiol (E2), estriol (E3), 16α-hydroxyestrone (HE1), 17α-ethinylestradiol (EE2), mestranol 
(ME), β-estradiol 17-acetate (E2Ac), β-estradiol 3-sulfate (E2S3) and estrone 3-sulfate 
(E1S3), roxithromycin (ROX), clarithromycin (CLA) and erythromycin (ERY) as its 
antibiotic active form, in influents and effluents of sewage treatment plants (STP) by HPLC-
MS/MS using the same sample and a single extraction and clean-up procedure. Such a 
multiresidue method is not described in the literature. Compliance within EU decision 
657/2002/EC was desired for this project [87]. This recommendation requests analysing two 
MRM transitions per analyte to exclude false positive results. 
 
4.1.2 Experimental to the method validation of hormones and 
antibiotics in wastewater 
4.1.2.1 Materials 
Water (HPLC grade) was obtained from Mallinckrodt Baker (Griesheim, Germany). 
Methanol, tert-butylmethylether (Suprasolv grade), ammonium acetate, acetone, ammonium 
hydroxide (analytical grade) and acetonitrile (Lichrosolv) were obtained from Merck 
(Darmstadt, Germany). Tetrahydofurane (analytical grade) was obtained from KMF-
Laborchemie (Lohmar, Germany). 
Estrone, estrone 2,4,16,16 - d4, estriol, 16α-hydroxyestrone, β-estradiol 3-sulfate sodium salt, 
estone 3-sulfate potassium salt, erythromycin and roxithromycin were provided by Sigma-
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Aldrich (Seelze, Germany). 17β-Estradiol hemihydrate, β-estradiol-17-acetate, 17α-
ethinylestradiol, mestranol (VetranalTM) were obtained from Riedel-de Haën (Seelze, 
Germany). Estrone 3-sulfate 2,4,16,16 - d4 sodium salt and 17α-ethinylestradiol 2,4,16,16 - d4 
were obtained from Dr. Ehrenstorfer GmbH (Augsburg, Germany). Clarithromycin was 
provided by Promochem (Wesel, Germany). The synthesis of (E)-9-[O-(2-methyloxime)]-
erythromycin is described by Schlüsener et al. 2003 [58] and in chapter 2.2.1.2. 
 
4.1.2.2 Internal Standards 
10 mg of 17α−ethinylestradiol - d4 (EE2 - d4) was dissolved in 90 mL acetone, the volume 
was calibrated to 100 mL with HPLC-water. 10 mg of estrone 3-sulfate 2,4,16,16 - d4 sodium 
salt (E1S3 - d4) was dissolved in 90 mL water and the volume was calibrated to 100 mL with 
acetone. The internal standard solution for the steroid hormones (IS-H) was made by dilution 
with methanol of these two stock solutions to a final concentration of 10 ng/µL. The internal 
standard for the analysis of the macrolide antibiotics was made by dissolving 10 mg  
(E)-9-[-O-(2-methyloxime)]- erythromycin in 100 mL acetonitrile (IS-A).  
 
4.1.2.3 Solid Phase Extraction 
The DVB-phobic Speedisk cartridges from Baker (8086, Bristol/PA, USA) were conditioned 
with 15 mL methanol followed by 15 mL HPLC-water. A solid-phase extraction manifold 
(IST, Grenzach-Wyhlen, Germany), with PTFE stopcock and outlet, was used. The 
wastewater samples (~1000 mL) were passed through the cartridge at a speed of 100 mL/min 
(vacuum) by means of a Speedisk sample remote adapter (Baker, Bristol/PA, USA). The 
exact volume of the water sample was determined by difference weighting. The cartridge was 
washed with 15 mL HPLC-water to remove ionic compounds and dried for 5 min by gently 
sucking air through the cartridge. The analytes were eluted from the cartridge with 15 mL 
tert-butylmethylether followed by 15 mL methanol in a 30 mL amber flask. 10 µL of internal 
standard solution for the analysis of steroid hormones (IS-H) and 10 µL internal standard 
solution for the analysis of macrolide antibiotics (IS-A) were added to the mixture. The flask 
was closed, shaken by hand for 10 seconds and stored at -18 °C prior to clean-up. 
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4.1.2.4 Size Exclusion Chromatography (SEC) clean-up 
Matrix components with high molecular masses were removed by SEC. The wastewater 
extract was condensed to 1 mL at 60 °C and 35 mbar by a Büchi Syncore® Analyst 12 port 
evaporation unit (Essen, Germany). The residue was dissolved in 10 mL tetrahydrofurane 
(THF) and the volume was reduced again to 1 mL at 60 °C and 35 mbar and one millilitre of 
THF:acetone, (70:30, v/v) was added. The complete sample was injected onto the SEC 
column. The SEC system consisted of a G1379A vacuum degasser, a G1311A quaternary 
pump equipped with a relay bus card (Agilent, Waldbronn, Germany), a rheodyne 7725i 
manual injection valve with a 2 mL sample loop (Rheodyne, Bensheim, Germany) and a C2-
2006D automatic valco valve (VICI AG, Schenkon, Switzerland) for fractionation. The size 
exclusion was performed on a Phenogel SEC column (21.2 mm i.d., length 300 mm, particle 
size 5 µm, 100 Å) (Phenomenex, Torrance, CA, USA) at ambient temperature in an air 
conditioned room at 24 °C. 
Time synchronisation between the injection and the fraction valve was triggered using a short 
contact closure signal of the injection valve to the pump. Also the pump gave a short closure 
signal at time step 21 min and 45 min to the fractionation valve. 
A mixture of THF:acetone, (70:30, v/v) was used as eluent at a flow rate of 3 mL/min. The 
first fraction from 0 min to 21 min, which contained the higher molecular weight compounds, 
was diverted to waste. The second fraction (21-45 min), which contained the hormones and 
antibiotics, was collected in a 100 mL amber flask. Afterwards, the column was rinsed for 
five minutes with the solvent prior to the next injection. The volume of the collected fraction 
was reduced to 1 mL by the Büchi evaporation unit at 60 °C and 35 mbar. The residue was 
dissolved in 10 mL methanol and the volume was reduced again to 1 mL at 60 °C and 35 
mbar. 
The best hard-cut and separation conditions of the SEC were studied with MS/MS detection 
while the SEC-column was connected via a micro-splitter valve (P-460S, Upchurch Scientific 
Inc., WA, USA) to the mass spectrometer (MS) and a split flow of 1 mL/min was introduced 
in the MS. 
4.1.2.5 HPLC  
The HPLC system consisted of a G1313A autosampler, a G1312A binary HPLC pump, a 
G1322A degasser and a G1316A column oven (all Agilent, Waldbronn, Germany). 
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Steroid hormones and conjugates 
Separations were performed using a Synergi RP-MAX column (2 mm i.d., length 150 mm, 
particle size 4 µm) and a SecurityGuard (Phenomenex, Torrance, CA, USA) at 25 ± 1 °C. The 
flow rate was 0.2 mL/min. The HPLC gradient was established by mixing two mobile phases: 
phase A: pure water and phase B: pure methanol. Chromatographic separation was achieved 
with the following gradient: 0-1 min: 0% B; 1 min to 3 min: 0% to 70% B; 3 min to 23 min: 
70% to 100% B; 23-29 min: 100% B; 29 min to 30 min: 100% to 0% B; 30-35 min: 0% B. 
Ten µL of each sample was injected. 
 
Macrolide antibiotics 
The HPLC separations of the macrolide antibiotics were performed using a Phenosphere-Next 
RP18 column (2 mm i.d., length 150 mm, particle size 3 µm) and a SecurityGuard at 25 ± 1 
°C. The flow rate was 0.2 mL/min. The HPLC gradient was established by mixing two mobile 
phases: phase A, 10 mM aqueous ammonia acetate solution and phase B, pure acetonitrile. 
Chromatographic separation was achieved with the following gradient: 0-1 min 10% B, 1 min 
to 14 min 10% to 100% B, 14-29 min 100% B, 29 min to 30 min 100% to 10% B, 30-35 min 
10% B. Ten µL of each sample were injected. An additional flow of 400 µL/min methanol 
was added after the separation by means of a second G1312A binary HPLC pump to improve 
the ionisation of the macrolide antibiotics in APCI mode. 
4.1.2.6 Mass spectrometry 
The triple quadrupole mass spectrometer (API 2000, Applied Biosystems, Darmstadt, 
Germany) was equipped with a TurboIonSpray source (ESI) and a Heated Nebuliser source 
(APCI). 
 
Steroid hormones and conjugates (ESI) 
The ESI source was operated under the following conditions: curtain gas (CUR), 40 psi; 
collision gas (CAD), 3 mTorr; ion spray voltage (IC), -4500 V; temperature (TEM), 400 °C; 
ion source gas 1 (GS1), 35 psi; ion source gas 2 (GS2), 70 psi; interface heater (ihe), on; 
focusing potential (FP), -350 V; entrance potential (EP), -10 V. The arrangement of the ESI-
spray to the orifice was va, 5 mm and h, 3 mm (Table 27). 
 
Steroid hormones and conjugates (APCI) 
The APCI source was operated under the following conditions: curtain gas (CUR), 35 psi; 
collision gas (CAD), 3 mTorr; nebuliser current (NC), 2 µA; temperature (TEM), 450 °C; ion 
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source gas 1 (GS1), 60 psi; ion source gas 2 (GS2), 15 psi; interface heater (ihe), on; focusing 
potential (FP), 350 V; declustering potential (DP), 11 V; entrance potential (EP), 10 V. 
The arrangement of the spray was vertical (va), 5 mm; horizontal (h), 3 mm to the orifice and 
the position of corona needle was va, 4 mm and h, 6 mm (Table 28). 
Both soft ionisation modes were used in comparison. 
 
Table 27: MS-conditions as well as retention time for the analysis of steroid hormones with 
electrospray ionisation in two time controlled experiments: (1) t1 = 0-13.5 min, (2) t2 = 13.5-
35 min. Maximum variation in retention time was not larger than ± 0.1 min. HPLC 
conditions: Methanol: water, Synergi-RP Max 
 RT 
[min] 
precursor 
ion 
[amu] 
product 
ion 
[amu] 
dwell time
[msec] 
collision 
energy 
[eV] 
declustering 
potential  
[V] 
E1S3 11.6 
349 
349 
269 
143 
100 
100 
-44 
-100 
-68 
-68 
v
q
E1S3-d4 11.6 
353 
353 
273 
147 
100 
100 
-45 
-76 
-68 
-68 
q
v
HE1 12.3 
285 
285 
145 
159 
100 
100 
-50 
-50 
-68 
-68 
v
q
E3 12.5 
287 
287 
171 
145 
100 
100 
-49 
-58 
-68 
-68 
v
q
EE2 14.6 
295 
295 
145 
159 
100 
100 
-60 
-47 
-80 
-80 
v
v
EE2-d4 14.6 
299 
299 
174 
161 
100 
100 
-60 
-47 
-80 
-80 
v
v
E1 14.9 
269 
269 
145 
159 
100 
100 
-47 
-47 
-140 
-140 
v
v
E1-d4 14.9 
273 
273 
147 
161 
100 
100 
-51 
-51 
-140 
-140 
E2 14.8 
271 
271 
145 
239 
100 
100 
-54 
-53 
-140 
-140 
v
v
E2Ac 18.4 
313 
313 
253 
145 
100 
100 
-38 
-59 
-68 
 
v
v
q: MRM transition used for quantification; v: MRM transition used for verification; amu: 
atomic mass unit 
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Table 28: MS-conditions as well as retention time for the analysis of steroid hormones with 
atmospheric pressure chemical ionisation. Maximum variation in retention time was not larger 
than ± 0.1 min. HPLC conditions: Methanol: water, Synergi-RP Max 
 RT 
[min] 
precursor 
ion 
[amu] 
product ion
[amu] 
dwell time
[msec] 
collision 
energy 
[eV] 
 
HE1 12.4 
287 
287 
251 
199 
100 
100 
21 
24 
v
q
EE2 14.6 
279 
279 
133 
159 
100 
100 
22 
27 
v
q
EE2-d4 14.6 
283 
283 
135 
161 
100 
100 
28 
31 
q
v
E1 14.9 
271 
271 
159 
133 
100 
100 
29 
27 
q
v
E1-d4 14.9 
275 
275 
161 
135 
100 
100 
29 
32 
 
E2 14.8 
255 
255 
159 
133 
100 
100 
24 
24 
v
q
E2Ac 18.4 
255 
255 
159 
133 
100 
100 
24 
24 
q
v
ME 20.1 
293 
293 
173 
147 
100 
100 
31 
27 
q
v
q: MRM transition used for quantification; v: MRM transition used for verification; amu: 
atomic mass unit 
 
Macrolide antibiotics (APCI) 
The APCI source operated under the following conditions: curtain gas (CUR), 50 psi; 
collision gas (CAD), 3 mTorr; nebuliser current (NC), 5 µA; temperature (TEM), 500 °C; ion 
source gas 1 (GS1), 80 psi; ion source gas 2 (GS2), 35 psi; interface heater (ihe), on; focusing 
potential (FP), 360 V; declustering potential (DP), 20 V; entrance potential (EP), 10 V. 
The arrangement of the spray was vertical (va), 5 mm; horizontal (h), 3 mm to the orifice and 
the position of corona needle was va, 4 mm and h, 6 mm. 
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Table 29: MS-conditions as well as retention time for the analysis of macrolide antibiotics 
with atmospheric pressure chemical ionisation. Maximum variation in retention time was not 
larger than ± 0.1 min. HPLC conditions: Acetonitrile: 10 mM aqueous ammonium acetate 
solution, Phenosphere-Next 
 
 RT 
[min] 
precursor 
ion 
[amu] 
product ion
[amu] 
dwell time 
[msec] 
collision 
energy 
[eV] 
 
Clarithromycin 13.7 
748 
748 
158 
590 
120 
80 
45 
25 
q
v
Erythromycin 12.8 
734 
734 
158 
576 
120 
80 
45 
25 
q
v
Roxithromycin 14.2 
837 
837 
158 
679 
120 
80 
46 
35 
q
v
Internal 
Standard (IS-A) 13.9 
763 
763 
158 
605 
120 
80 
45 
25 
q
v
q: MRM transition used for quantification; v: MRM transition used for verification; amu: 
atomic mass unit 
 
MS calibration was performed up to m/z 1800 with mass resolution of quadrupole 1 and 
quadrupole 3, both were set to 0.7 Daltons. The data obtained were processed using 
AnalystTM 1.4 software. To gain higher selectivity, multiple reaction monitoring (MRM) was 
chosen. MS/MS parameters were optimised in continuous flow mode, injecting 1,000 ng/mL 
standard solutions dissolved in methanol at a flow rate of 10 µL/min. The optimal collision 
energy (CE) and optimal declustering potential (DP) was determined by means of a software 
procedure controlling the automatic switching between the different voltages with a step size 
of 1 V/scan and a range from -5 to -130 V in positive mode and 5 to 130 V in negative mode 
for the CE and 0 to 200 V in positive mode and 0 to -200 V in negative mode for the DP. The 
MRM transitions as well as the individual declustering potential and collision energy voltage 
used for the analysis of steroids hormones in ESI and APCI mode are displayed in Table 27 
and Table 28. The ‘q’ indicates the MRM transition that was used for quantification, all other 
transitions were used for verification (v). 
The macrolide antibiotics are analysed more reliably in APCI as demonstrated for manure 
[58]. The parameters used in this study are demonstrated in Table 29. 
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4.1.2.7 Calibration  
The calibration was performed as an internal standard calibration. A stock solution for the 
hormones was produced by dissolving 10 mg of the hormones in 30 mL acetone, 30 mL water 
and filled up to 100 mL with acetonitrile. A stock solution for the macrolide antibiotics was 
produced by dissolving 10 mg of the respective antibiotics in 100 mL acetonitrile. These 
stock solutions were stored at 4 °C in the dark and were renewed after 3 months. Calibration 
standards (1, 5, 10, 50, 100, 500, and 1,000 ng/mL) were made by serial dilution of the stock 
solution in methanol. Ten micro litre of each internal standard solution were added to each 
millilitre of the calibration standards. The calibration curves were calculated using a weighted 
(1/X) linear regression model. 
4.1.3 Results and discussion to the method validation of hormones 
and antibiotics in wastewater 
All analytes were separated by HPLC. The calibration graphs are linear in the range from the 
limit of quantification (LOQ) up to 1,000 ng/mL with correlation coefficients (R2) better than 
0.99. 
 
Optimisation of ESI-signals:  
The addition of buffers (ammonium acetate, ammonium formiate or ammonium hydroxide at 
varying concentrations, pH 3-11) to the mobile phase caused a decrease in the responses of 
the analytes due to lower ionisation ratios for the separation of steroid hormones. The use of 
pure methanol instead of pure acetonitrile as phase B gave factor 2-3 higher ionisation ratios 
in electrospray ionisation mode for these analytes. These results correspond with the literature 
[84, 88]. The postcolumn addition of a 40 mmol/L methanolic ammonia solution gave a 
decreasing of the response of the analytes in ESI negative mode. These results are different to 
Bartonti et al. [89] and Gentili et al. [90] who also used an API 2000 mass spectrometer and 
detected better ionisation ratios with the postcolumn addition of ammonia. 
 
Optimisation of APCI signals:  
The addition of ammonium acetate to the mobile phase of the macrolide antibiotics increased 
the ionisation performance of these analytes. Also the postcolumn addition of 400 µL/min 
methanol improved the ionisation of the macrolide antibiotics. 
Thus, three HPLC-MS/MS methods are necessary for an optimal ionisation of all analytes. 
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4.1.3.1 The choice of internal standards 
The use of estrone 2,4,16,16 - d4 from Sigma-Aldrich as internal standard in an amount of 
25 ng resulted in interferences with the corresponding undeuterated target compound up to 
concentrations of 3 ng/L, though Sigma-Aldrich claims an isotopic purity of 95 %. For this 
reason, the use of estrone 2,4,16,16 - d4 was avoided in the final method.  
The use of sodium estrone 3-sulfate 2,4,16,16 - d4 and 17α-ethinylestradiol 2,4,16,16 - d4 
from Dr. Ehrenstorfer GmbH as internal standards gave no interference with the 
corresponding undeuterated target compound. E1S3, E2S3 and E3 were quantified with 
sodium estrone 3-sulfate 2,4,16,16 - d4 as internal standard. 17α-ethinylestradiol 2,4,16,16 - d4 
was used to quantify E1, E2, EE2, ME, HE1 and E2Ac. 
The use of (E)-9-[-O-(2-methyloxime)]- erythromycin as internal standard for the 
quantification of the macrolide antibiotics gave no blank problems. 
 
4.1.3.2 Peak identification 
EU decision 2002/657/L221 requires four identification points for the identification in HPLC-
MS/MS analysis [87]. By using the HPLC-MS/MS technique, each precursor ion results in 
one identification point, while each transition product ion is counted as 1.5 points. Therefore, 
four points can be obtained by measuring one precursor and two product ions. Additionally 
the ratio of the chromatographic retention time of the analyte to that of the internal standard, 
the relative retention time of the analyte, shall correspond to that of the calibration solution at 
a tolerance of ± 2.5 % [87]. 
Figure 24 shows the MRM chromatograms of ethinylestradiol and its internal standard, 
ethinylestradiol - d4, in a standard solution and a STP-influent sample. By using only the first 
MRM transition and the ± 2.5 % tolerance of the retention time criterion to identify the 
respective peak resulted in a false positive identification. Only using a second MRM 
transition for verification gave a correct result. 
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Figure 24: MRM chromatograms of 17α-ethinylestradiol and its internal standard, 
ethinylestradiol - d4, in an standard solution and a STP-influent sample. A false positive 
determination is detected by the missing peak in the second MRM. 
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4.1.3.3 Matrix effects 
A main problem in the quantitative liquid chromatography coupled with tandem mass 
spectrometry is the unexpected matrix effect. Different strategies are established to 
compensate these matrix effects: 
 
1) Matrix calibration:  
This is an internal standard calibration in the presence of a uncontaminated matrix to account 
matrix effects [50, 51]. This matrix is produced from uncontaminated samples by the same 
sample preparation, which is used for the analysis of the samples and is added to the 
calibration standards. A matrix calibration is working well, if there is access to 
uncontaminated sample matrix. It is difficult to obtain matrix wastewater samples free of 
natural steroid hormones and antibiotics. 
 
2) Standard addition:  
The sample is divided into several sub-samples and standard calibration solution is added to 
the sub-samples [91, 92]. As a result, a calibration curve is generated for each sample. This 
method is working well with a low number of samples but it is impracticable with high 
sample throughput, as it causes multiplication of analysis time because the number of samples 
is multiplied by the number of standards. 
 
3) Isotope dilution:  
The quantification with isotopic labelled internal standards. These standards have the same 
chemical nature, co-elute with the respective analyte and the matrix. Thus the same effect 
occurs to the internal standard as well as to the analyte. A disadvantage is the less availability 
of these standards. 
 
All three options can compensate the matrix effects, but none of these options reduce these 
effects. Figure 25 shows the matrix effects of 17α-ethinylestradiol 2,4,16,16 - d4 at a 
concentration of 100 ng/mL with electrospray ionisation (ESI). In spite of an elaborated 
clean-up procedure this internal standard shows a 31 times lower signal in an influent sample 
due to matrix effects while a 9-fold decrease is observed for effluent samples. As a 
consequence of these high matrix effects quantification is difficult at concentrations levels 
near the original LOQ. This implies that the limits of quantification are raising.  
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Figure 25: ESI MRM chromatograms of 17α-ethinylestradiol 2,4,16,16 - d4 in a standard 
solution in comparison to extracts of effluent and influent from STP samples (peak height) 
spiked to 100 ng/mL, each. The resulting matrix effect is calculated by dividing the peak 
height (intensity) for the IS of the standard solution by the peak height for the IS of the 
respective sample extract. 
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To reduce these matrix effects chemical ionisation at atmospheric pressure (APCI) can be 
utilised successfully. Figure 26 shows the chromatograms of 17α-ethinylestradiol 2,4,16,16 - 
d4 in the same samples (standard, influent and effluent) as discussed above for ESI. Compared 
to the standard solution the ionisation of EE2-d4 in the influent and effluent was only a factor 
3.5 smaller while in ESI this effect was factor 31. Thus matrix effects in APCI-mode were 
about factor 3-10 less pronounced than in the ESI-mode. Similar effects have been observed 
for different matrices and ion sources from other manufactures in the literature [58, 91]. 
Thus the atmospheric pressure chemical ionisation is preferable to the electrospray ionisation 
for the analysis of steroid hormones in wastewater samples. Unfortunately, not all analytes 
could be ionised by APCI, therefore E1S3, E2S3 and E3 were quantified by ESI-MS/MS. 
However, the matrix effects for these three hormones were much lower than for the later 
eluting steroid hormones. 
The comparison of ESI and APCI for the analysis of macrolide antibiotics is described in 
Schlüsener et al. [58]. It revealed similar results as obtained in this study focussing on 
hormones. 
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Figure 26: APCI MRM chromatograms of 17α-ethinylestradiol 2,4,16,16 - d4 in a standard 
solution in comparison to extracts of effluent and influent from STP samples (peak height) 
spiked to 100 ng/mL, each. The resulting matrix effect is calculated by dividing the peak 
height (intensity) for the IS of the standard solution by the peak height for the IS of the 
respective sample extract. 
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4.1.3.4 Validation of the method 
The method was primarily validated by spiking 1 L of tap water with the stock solutions to 
produce concentrations of 1, 3, 10, 30, 100, 300 and 1,000 ng/L. The following sample 
preparation, extraction and clean-up was identical to the procedures described above. These 
recovery experiments for hormones and antibiotics were carried out at seven concentration 
levels in triplicate.  
The recovery rates are given in Table 30. Since there was no significant concentration (1, 3, 
10, 30, 100, 300 and 1,000 ng/L) dependency of the recovery rate, the values of all 
experiments were averaged. The limit of quantification (LOQ) was defined as a signal-to-
noise ratio of 10:1 and the limit of detection (LOD) as a signal-to-noise ratio of 3:1. The 
signal-to-noise ratios of the LOD and LOQ were taken from the chromatograms of the 
recovery rates. 
Mean recovery rates of the steroid hormones in APCI-mode ranged from 82% (RSD 12%) to 
109% (RSD 15%). Mean recoveries of 58% (RSD 24%) for estriol, 95% (RSD 13%) and 92% 
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(RSD 9%) for the hormone-sulfates were obtained using the electrospray ionisation. This 
method was also applied to β-estradiol 17-β-D-glucuronide but it did not give constant 
recovery rates for this compound. The mean recovery rates for the macrolide antibiotics were 
79 % (RSD 11%) for roxithromycin, 82 % (RSD 7%) for clarithromycin and 100 % (RSD 
15%) for erythromycin (Table 30). 
4.1.3.5 Stability of the method in respect of matrix and during sample transport 
and storage 
To proof the stability of the analytical method eleven 1 L STP influent samples were spiked 
with 100 ng of the respective analytes. Five spiked samples were extracted immediately, five 
samples were stored in the dark at 4 °C for 48 hours before the extraction. The sample 
preparation, extraction and clean-up of these ten samples were identical to the procedures 
described above. The last sample was extracted directly after spiking, but this sample received 
no SEC clean-up. Another two unspiked influent samples were also analysed to determine the 
blank levels. Table 30 shows the recovery rates of the spiked influent samples. The recovery 
rates of the spiked wastewater samples were all identical to those obtained from spiked tap 
water within the precision of the method.  
In comparison with stored samples only a degradation of mestranol and β-estradiol 17-acetate 
was observable in the same experiment. The “recovery” was reduced from 97% to 68% for 
mestranol while those of β-estradiol-17-acetate changed from 112% to 58%. β-Estradiol 3-
sulfate shows a maximal “increase” of 10 % of the concentration. The recovery rates of all 
other analytes were identical to those extracted immediately from wastewater and tap water. 
 
4.1.3.6 Comparison between samples with and without clean-up 
The different recovery rates of the uncleaned sample (without SEC) in comparison to the 
cleaned samples based on the different matrix effects of the internal standards to their 
respective analytes. In comparison to samples that were processed with clean-up to those that 
were processed without clean-up revealed lower results considering: estrone, the macrolide 
antibiotics and estriol using APCI and ESI respectively. 
The limit of quantification, defined as the signal to noise ratio of 10:1, in wastewater influent 
samples were about maximal two times higher than in tap water samples in APCI mode. In 
ESI mode the LOQ increased by the factor of 7 (Table 30). 
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Table 30: Mean recovery rate as well as standard deviation, relative standard deviation 
(RSD), and limit of quantification (LOQ), (three extractions, repetitions for each 
concentration level) of hormones and antibiotics in tap water. Recoveries were determined at 
concentrations of 1, 3, 10, 30, 100, 300 and 1000 ng/L water. Also mean recovery rate 
± standard deviation of five spiked STP influent samples, mean recovery ± standard deviation 
of five spiked STP influent samples stored for 48h at 4°C, recovery of one spiked influent 
sample without SEC clean-up and limit of quantification (LOQ) of hormones and antibiotics 
in wastewater influents. LOQ: S/N = 10:1 
  
Mean 
recovery 
[%] 
 
tap water 
n=21 
RSD
 
[%] 
Mean 
recovery
  
[%] 
influent 
n=5 
Mean 
recovery 
after  
48 h [%]
influent 
n=5 
Recovery 
without  
SEC  
[%] 
 
n=1 
LOQ  
[ng/L] 
 
effluent 
tap 
water 
LOQ 
[ng/L]
 
influent
Hormones (APCI)   
   
  
Mestranol 105±12 11 97±12 68±7 73 3 6 
16α-Hydroxyestrone 74±15 21 86±13 75±8 87 8 8 
17β-Estradiol 98±9 9 83±8 88±7 87 8 8 
Estrone 105±16 15 90±12 113±11 64 2 4 
17α-Ethinylestradiol 83±6 7 85±9 82±4 82 6 6 
17β-Estradiol-17-
acetate 109±15 14 112±17 51±6 104 1.5 3 
Hormones (ESI)        
β-Estradiol 3-sulfate 92±8 9 95±7 119±11 98 1.8 28 
Estrone 3-sulfate 95±12 13 77±8 76±7 74 0.6 4 
Estriol 58±14 24 63±19 43±9 16 15 35 
Antibiotics (APCI)        
Clarithromycin 82±6 7 91±7 91±12 30 2 2 
Erythromycin 100±15 15 82±9 81±9 13 6 6 
Roxithromycin 79±8 11 92±9 86±23 33 6 6 
n: number of spiked extracted samples 
Antibiotics and steroid hormones in wastewater 
 70
4.1.3.7 Application to environmental samples 
The method was tested for several wastewater samples in order to investigate the fate of 
hormones and antibiotics during wastewater treatment. Wastewater from a sewage treatment 
plant in the Ruhr region of North Rhine Westphalia (Germany) with 250,000 inhabitant 
equivalent values was sampled during four days. The samples were taken automatically as 24-
hour composite samples at the inflow and effluent of a sewage treatment plant. The samples 
were refrigerated at 4 °C during the 24 h intervals. They were transported to the laboratory 
immediately after sampling and extracted within 6 hours after arrival. The samples were 
generally extracted on the same day. When it was not possible to extract the hormones 
immediately, the samples were stored at 4 °C for two days maximum. All extractions were 
performed in duplicate. 
The steroid hormone 17β-estradiol was found with concentration up to 22 ng/L in influents 
and 8.6 ng/L in effluents (Table 31). The metabolites of 17β-estradiol, estrone, 16α-
hydroxyestrone and estriol were determined with maximal concentrations of 87 ng/L (E1), 90 
ng/L (HE1) and 470 ng/L (E3) in influents and 5.3 ng/L (E1), 14 ng/L (HE1) and 99 ng/L 
(E3) in effluents. These results were in the same order of magnitude as the results of Bartoni 
et al. [89] and Gentili et al. [90] who measured steroid hormones in influents and effluents of 
different sewage treatment plants in Italy. The conjugates of the steroid hormones were found 
at maximal concentrations of 8 - 28 ng/L (E2S3) and 23 ng/L (E1S3) in influents in the Ruhr 
region. These results correspond with Gentili et al. [90] who found E1S3 in concentrations up 
to 3.9 ng/L. Estradiol 3-sulfate was found at maximal concentrations of 37 ng / L (E2S3) and 
estrone 3-sulfate 14 ng/L (E1S3) in effluents in the Ruhr region. These results match with the 
results of Isobe et al. [93] who analysed nine steroid hormone conjugates in effluents of 
Japanese STPs and found only E1S3 and E2S3 in concentrations of 0.3-2 ng/L. The 
contraceptives mestranol, 17α-ethinylestradiol and β-estradiol 17-acetate were neither 
detected in inflow nor in effluent samples of this sewage treatment plant in the Ruhr region. 
The concentrations of 17α-ethinylestradiol in wastewater were below the limit of detection 
(2 ng/L). Similar results considering inflow and outflow data for estrone and estriol were 
obtained by Bartoni et al. [89]. However, Bartoni et al. [89] found 17α-ethinylestradiol up to 
concentration of 0.4 - 13 ng/L in influents of Italian STPs.  
Maximal concentrations of macrolide antibiotics in influents were found to be 370 ng/L 
(CLA), 160 ng/L (ROX) and 1,200 ng/L for erythromycin. In effluents concentrations of 
antibiotics were 230 ng/L (CLA), 130 ng/L (ROX) and 320 ng/L for erythromycin. Compared 
with the results of an other German group that measured only anhydroerythromycin [15] these 
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values are in same range. In comparison with values from STPs of Switzerland [35] the data 
from the Ruhr region were higher. Table 31 shows the concentrations in inflow and effluent 
samples of the hormones and antibiotics at four different sampling days with different 
weather conditions. 
 
Table 31: Concentrations of influents and effluents at four different sampling days of a STP 
in the Ruhr region of North Rhine Westphalia (Germany) with 250,000 inhabitant equivalent 
values and different weather conditions. The deviation based on the relative standard 
deviation of the validated method. 
  
day 1 
[ng/L] 
day 2 
[ng/L] 
day 3 
[ng/L] 
day 4 
[ng/L] 
influent 18±2 12±1 11±1 22±2 
17β-Estradiol 
effluent - - 8.6±0.8 2.4-8* 
influent 45±7 87±13 42±6 32±5 
Estrone 
effluent 4.6±0.7 5.3±0.8 - 2.0±0.3 
influent 13±2 90±14 18±3 9.5±1.4 
16α-Hydroxyestrone 
effluent 2.4-8* 6.7±1.0 14±2 6.8±1.0 
influent 54±13 470±110 66±16 55±13 
Estriol 
effluent 20±5 99±24 4.5-15* - 
influent - 8-28* - - 
β-Estradiol 3-sulfate 
effluent - 6.4±0.6 3.0±0.3 37±3 
influent 1.2-4* 23±3 12±2 5.3±0.7 
Estrone 3-sulfate 
effluent 4.1±0.5 3.0±0.4 1.9±0.3 14±2 
influent 180±12 370±26 210±15 81±6 
Clarithromycin 
effluent 130±9 230±16 220±16 81±6 
influent 180±27 1200±180 850±130 97±15 
Erythromycin 
effluent 180±27 320±48 270±41 66±10 
influent 96±13 160±23 110±15 54±8 
Roxithromycin 
effluent 63±9 110±15 130±18 38±5 
* : Value <LOQ ; - :<LOD; Ethinylestradiol < LOD (2 ng/L) 
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4.1.4 Conclusions to the method validation of hormones and 
antibiotics in wastewater 
A reliable multiresidue method with low LOQs has been developed to analyse steroid 
hormones, their conjugates, the synthetic contraceptives and macrolide antibiotics unaltered in 
unfiltered influents and effluents of sewage treatment plants. This method can be used to 
investigate the fate of these compounds in various steps of wastewater treatment.  
Solid phase extraction followed by a SEC clean-up step resulted in sufficiently clean extracts, 
which were analysed by HPLC-APCI-MS/MS and HPLC-ESI-MS/MS. The electrospray 
ionisation was compared to atmospheric pressure chemical ionisation considering matrix 
effects in HPLC-MS/MS analysis. The atmospheric pressure chemical ionisation mode should 
be preferred to electrospray ionisation even though less sensitivity is obtained in standard 
solutions. The reduction of matrix effects in APCI mode is an advantage of this ion source. 
For the analysis of hormones in wastewater, it is important to follow on the EU decision 
2002/657/L221 to prevent false positive results. The use of a second MRM is essential for 
verification. 
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4.2 Fate of antibiotics and steroid hormones during 
wastewater treatment 
4.2.1 Introduction to the fate of hormones and antibiotics in 
wastewater 
Wastewater is treated predominantly by a combination of mechanical, biological and 
chemical treatment steps in Germany before a discharge into surface waters occurs. The 
elimination of nutrients and harmful substances are thus performed in multistage processes of 
municipal sewage treatment plants. However, every STP is a unique system with different 
arrangements of mechanical, biological and chemical processes i.e. nitrification, 
denitrification, phosphate precipitation, neutralisation, activated-sludge and trickling filter 
techniques. Different executions and arrangements of these techniques result in different 
elimination rates of organic pollutions. 
For the municipal sewage treatment plant operators as well as planners of such plants it is of 
outstanding relevance to know whether and how the elimination of organic pollutants in STPs 
is performed. It is an advantage to know by which procedural modification a better 
elimination of relevant harmful substances occurs. 
A part of the published literature tries to describe the elimination of steroid hormones and 
estrogenic active compound in only one STP [94, 95] at two sampling days and two-times at 
one sampling day respectively. Ternes et al. tested two STPs in Germany and Brazil over a 
period of six days [80]. They found elimination rates of 83 % for estrone and 99.9 % for 
17 β-estradiol in a German plant. Schullerer et al. examined three plants in Baden-
Württemberg, Germany [96]. One plant was tested over a period of seven days. Elimination 
rates ranged from 87 %- 92 % for steroid hormones. The other two plants were only sampled 
on one day.  
In this study, three STPs in North Rhine-Westphalia, Germany, with different concepts of 
wastewater treatment were chosen in order to investigate their efficiency in eliminating of 
macrolide antibiotics, steroid hormones, oral contraceptives and hormone conjugates over 
four weeks, considering hydraulic retention times as well as sludge retention times. 
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4.2.2 Experimental to the fate of hormones and antibiotics in 
wastewater 
 
Chemicals, solid phase extraction, SEC clean-up, HPLC and mass spectrometry conditions 
were the same as described previously (chapter 4.1.2.1). 
 
4.2.2.1 Description of the sample sites 
STP 1 
Sewage treatment plant 1 is a middle-sized plant with 250,000 inhabitant equivalent values. 
The average wastewater inflow per day is 70,000 m³. This plant is equipped with an aerated 
grit chamber, a primary settling tank, two aeration basins, a circular aeration basin and a final 
settling tank. The denitrification step is disposed upstream while the precipitation of 
phosphate occurs by means of ferric salts. The inflow was sampled before the processed water 
of the sludge dewatering is added to the wastewater. The effluent was tested before the 
cleaned wastewater was discharged into the river. Figure 27 gives a more detailed insight into 
the wastewater treatment process of this STP. The samples were taken during the period from 
31.08.04 till 26.09.04. 
 
STP 2 
Sewage treatment plant 2 is smaller than STP 1 with 64,000 inhabitant equivalent values. The 
average wastewater inflow per day is 12,000 m³. This plant is equipped with a neutralization 
line, an aerated grit chamber, a preliminary settling tank, a trickling filter and a final settling 
tank and finally a postdenitrification step. The precipitation of phosphate occurs by means of 
ferric salts after the trickling filters. The inflow was sampled after the screen cleaner and 
before the neutralization line. The effluent was tested directly after the denitrification and 
before the tertiary ponds. After the tertiary ponds the wastewater was discharged into the 
river. The technical sketch of this STP gives a more detailed insight into this wastewater 
treatment process (Figure 28). The samples were taken during the period from 28.02.05 till 
30.03.05. 
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Figure 27: Technical sketch of STP 1 with 250,000 inhabitant equivalent values.  
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Figure 28: Technical sketch of STP 2 with 64,000 inhabitant equivalent values. 
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STP 3 
Sewage treatment plant 3 is a small plant with 32,000 inhabitant equivalent values. The 
average wastewater inflow per day is 13,000 m³. This plant is equipped with a grit chamber, a 
aeration basin with simultaneous nitrification and denitrification and a final settling tank. The 
precipitation of phosphate occurs by means of aluminium salts at the inflow. The inflow was 
sampled after the screen cleaner and before the phosphate precipitation. The effluent was 
tested before the cleaned wastewater was discharged into the river. Additionally, every three 
days the effluent of the final settling tanks was also tested. A detailed insight into this 
wastewater treatment process is shown in Figure 29. The samples were taken during the 
period from 06.06.05 till 03.07.05.  
Supplementary, a 24-h characteristic curve were taken in 2-h steps at the inflow of this plant. 
 
All samples were taken automatically as 24-hour composite samples. The samples were 
refrigerated at 4 °C during the 24 h intervals. They were transported to the laboratory 
immediately after sampling and extracted within 6 hours after arrival. The samples were 
generally extracted on the same day. When it was not possible to extract the hormones and 
antibiotics immediately, the samples were stored at 4 °C for two days maximum. All samples 
were extracted in duplicates. 
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Figure 29: Technical sketch of STP 3 with 32,000 inhabitant equivalent values. 
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4.2.3 Results and discussion to the fate of hormones and 
antibiotics in wastewater 
During the complete sampling periods of all three STPs, no mestranol, 17α-ehinylestradiol 
and β-estradiol 17-acetate could be detected. Detailed information of the concentration and 
day by day load is presented in the supplement (chapter 10) and will be presented in the final 
report of the project BASPiK [97] 
 
4.2.3.1 STP 1 
 
Steroid Hormones 
The daily inflow load of the steroid hormones ranged from 0.1 g up to 14 g during dry 
weather conditions, depending on the different types of hormones. During the rainfalls, the 
wastewater flow-rate roses up from 40,000 m³/d to 180,000 m³/d. Also the inflow load of the 
steroid hormones rose up to 20 g/d respectively. As the steroid hormones are excreted by 
humans via the urine and the excretion rate does not raise up during rainfalls, the higher loads 
in the wastewater flow of this hormones stems from hormones bound to sediments which 
were transported to the STP due to high flow-rates in the sewers. 
 
Figure 30: Daily loads of estrone in the inflow and the effluent of STP 1 over the sampling 
period. Additionally the wastewater flow-rate during the sampling period is given. 
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Figure 31: Daily loads of hydroxyestrone in the inflow and the effluent of STP 1 over the 
sampling period. Additionally the wastewater flow-rate during the sampling period is given. 
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As examples for all steroid hormones Figure 30 and Figure 31 show the daily loads of estrone 
and hydroxyestrone during the sampling period, respectively.  
The concentrations ranged from 19 - 130 ng/L for estrone, <LOD – 110 ng/L for 
hydroxyestrone, up to 68 ng/L for estradiol, 510 ng/L maximum for estriol, up to 12 ng/L for 
estrone 3-sulfate and <LOD – 28 ng/L for β-estradiol 3-sulfate in influents. The effluents had 
generally lower concentrations.  
By comparing the loads of the influents with the load of the effluents, an elimination rate was 
calculated (Table 32). While the elimination of estrone is nearly 100 % the elimination of the 
other hormones ranged from 41% - 75 %, excepting β-estradiol 3-sulfate. No significant 
elimination could be observed during the wastewater treatment in this plant. 
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Table 32: Elimination rates of steroid hormones and macrolide antibiotics in the three 
investigated STPs. The elimination rates based on the complete mass flow rates during the 
sampling period. The standard deviation based on the SD of the validated method and 
Gaussian error propagation. Negative values indicate “generation”. Positive values indicate 
“elimination”. 
STP 1 STP 2 STP 3  
Elimination [%] Elimination [%] Elimination [%] 
Estrone 92 ± 2 -72 ± 36 50 ± 11 
16 α-Hydroxyestrone 69 ± 9 64 ± 11 82 ± 5 
17β-Estradiol 75 ± 3 -53 ± 19 26 ± 9 
Estriol 58 ± 14 34 ± 23 69 ± 11 
Estrone 3-sulfate 13 ± 16 -360 ± 85 73 ± 5 
β-Estradiol 3-sulfate 41 ± 14 -74 ± 15 13 ± 10 
Erythromycin 23 ± 16 0 ± 21 15 ± 18 
Clarithromycin -14 ± 10 -3 ± 9 -7 ± 9 
Roxithromycin -19 ± 18 -22 ± 19 -22 ± 27 
 
Figure 32: Elimination rates of estrone in STP 1 during the sampling period in comparison to 
the wastewater flow-rate. 
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The day to day variation of the elimination rate of estrone in this STP is nearly uninfluenced 
by rainfalls (Figure 32), except the heavy rainfalls at the end of the sampling period can 
disturb the elimination of estrone in this STP. Hydroxyestrone as an example for all other 
steroid hormones shows a decrease of the elimination efficiency during rainfalls (Figure 33). 
In the beginning of the sampling period the elimination rate of hydroxyestrone is nearly 100 
%. After the rain event at 11.09.04 the elimination rates ranges from 60% - 90%, while the 
elimination was complete disabled during and after the rain event from 21.09-26.09.04. 
The biological step of the STP was not able to handle the large inflow of wastewater 
considering the elimination of this compound. Maybe the bacteria which were responsible for 
the elimination of hormones needs time to adapted on the new situation after rainfalls. 
 
Figure 33: Elimination rates of hydroxyestrone in STP 1 during the sampling period in 
comparison to the wastewater flow-rate. 
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Antibiotics 
The daily inflow load of the macrolide antibiotics ranged from 0.9 g up to 60 g during dry 
weather conditions. During the rain events the loads raises up to 130 g per day. The 
concentrations ranged from 32 – 1,500 ng/L for erythromycin, 11 - 760 ng/L for 
clarithromycin and 1.8 – 155 ng/L for roxithromycin in influents. The effluents had maximal 
concentration of 460 ng/L (ERY), 250 ng/L (CLA) and 126 ng/L (ROX).  
As an example for all three macrolide antibiotics the daily loads of erythromycin during the 
sampling period is shown in Figure 34. During rain events the load of the antibiotics is also 
raising. This had the same explanation as discussed above for the steroid hormones. However, 
in the beginning of the sampling period, the load of erythromycin in the effluents were higher 
than in the corresponding influent. This phenomenon occurs only in this STP. Perhaps 
consumers of this antibiotic discharged this drug via the toilet and the active substance is 
released during the treatment process. 
 
Figure 34: Daily loads of erythromycin in the inflow and the effluent of STP 1 over the 
sampling period. Additionally the wastewater flow-rate during the sampling period is given. 
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The overall elimination rate of erythromycin in this STP was 23 % while the semi synthetic 
macrolide antibiotics clarithromycin and roxithromycin were not eliminated. This corresponds 
to the findings of other authors [29, 98]. 
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4.2.3.2 STP 2 
 
Steroid Hormones 
The daily inflow load of the steroid hormones ranged from 0.1 g up to 1.5 g during dry 
weather conditions, depending on the different types of hormones. For the duration of 
rainfalls, the wastewater flow-rate raises up from 9,000 m³/d to 32,000 m³/d. Also the inflow 
load of the steroid hormones raises up to 9 g/d for estriol. 
 
 
Figure 35: Daily loads of estrone in the inflow and the effluent of STP 2 (trickling filter) over 
the sampling period. Additionally the wastewater flow-rate during the sampling period is 
given. 
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Figure 36: Daily loads of hydroxyestrone in the inflow and the effluent of STP 2 (trickling 
filter) over the sampling period. Additionally the wastewater flow-rate during the sampling 
period is presented. 
Hydroxyestrone - STP 2
0.0
0.5
1.0
1.5
2.0
2.5
3.0
28
.0
2.
05
01
.0
3.
05
02
.0
3.
05
03
.0
3.
05
04
.0
3.
05
05
.0
3.
05
06
.0
3.
05
07
.0
3.
05
08
.0
3.
05
09
.0
3.
05
10
.0
3.
05
11
.0
3.
05
12
.0
3.
05
13
.0
3.
05
14
.0
3.
05
15
.0
3.
05
16
.0
3.
05
17
.0
3.
05
18
.0
3.
05
19
.0
3.
05
20
.0
3.
05
21
.0
3.
05
22
.0
3.
05
30
.0
3.
05
0
5000
10000
15000
20000
25000
30000
35000
Influent
Effluent
Flow-rate
Load [g/d] Flow-rate [m³/d]
 
 
By comparing the loads of the inflow with the load of the effluent, an elimination rate was 
calculated (Table 32). While the elimination of hydroxyestrone was 60 % (mean value) and 
those of estriol 34 %, respectively, an elimination of the other hormones was not observed. In 
contrast an increase of estrone up to 76 % was determined and both hormone sulfate rose 
about 74 % and 360 %, respectively. This phenomenon could be explained with the 
assumption that other conjugates like disulfates and sulfate-glucuronides which were not 
measured, were transformed to β-estradiol 3-sulfate during the wastewater treatment. A 
transformation of estrone 3-sulfate and other hormone-sulfates to β-estradiol 3-sulfate is 
possible. 
The increase of the steroid hormones based on the transformation of hydroxyestrone to 
estrone and estradiol is shown in Figure 37. This transformation is described in the literature 
[99]. The sum of the total inflow load of these three hormones in STP 2 was 54 g in 
comparison to the sum of the total outflow load 53 g. Thus, no elimination of steroid 
hormones could be achieved by using a trickling filter for wastewater treatment. 
The elimination of 16 α-hydroxyestrone as well as estriol during the complete sampling 
period also shows a decrease of the elimination efficiency during rainfall. This STP type is 
also vulnerable for heavy rain events. 
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Figure 37: Possible transformation route of hydroxyestrone to estrone and estradiol in STP 2 
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Figure 38: Elimination rates of hydroxyestrone in STP 2 (trickling filter) during the sampling 
period in comparison to the wastewater flow-rate. 
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Antibiotics 
The daily inflow load of the macrolide antibiotics ranged from 0.3 g up to 7 g. The 
concentrations ranged from 73 - 650 ng/L for erythromycin, 97 - 690 ng/L for clarithromycin 
and 16 – 250 ng/L for roxithromycin in influents. The effluents had maximal concentrations 
of 440 ng/L (ERY), 480 ng/L (CLA) and 350 ng/L (ROX).  
As an example for all three macrolide antibiotics, Figure 39 shows the daily loads of 
erythromycin during the sampling period. 
 
Figure 39: Daily loads of erythromycin as an example for the macrolide antibiotics in the 
inflow and the effluent of STP 2 (trickling filter) over the sampling period. Additionally the 
wastewater flow-rate during the sampling period is presented. 
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The macrolide antibiotics were not eliminated in this STP during the sampling period. Thus, 
the trickling filter technique does not eliminate macrolide antibiotics during wastewater 
treatment. 
 
 
 
 
Antibiotics and steroid hormones in wastewater 
 88
4.2.3.3 STP 3  
Steroid Hormones 
Figure 40 shows a diurnal cycle of the inflow load of three hormones. Samples were taken in 
two hour intervals for 24 hours. The loads decreased during nighttime and rose in the morning 
and evening. While the flow-rate decreased about 50 % during the night, 16 α-hydroxyestrone 
decreases from 140 mg/2h between 16-18 o’clock to 38 mg/2h between 6-8 o’clock. All other 
steroid hormones behave similar. This decreasing overnight and increasing in the morning 
indicates that the steroid hormones stem from excretion by humans. While most people sleep 
over night, the excretion of hormones via the urine is low. Due to the morning act of urination 
the excretion of the hormones increases. 
Additionally it will be clear why a 24-h flow controlled composite sampling is important for 
this project. One time sampling of the influent and effluent gives only a snapshot with no 
information about elimination rates.  
 
Figure 40: Two hours inflow loads of three hormones over one day in STP 3. 
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The daily inflow load of the steroid hormones in STP 3 ranged from 0.1 g up to 4.2 g during 
dry weather conditions, depending on the different types of hormones. During rainfalls, the 
wastewater flow-rate rose from 8,000 m³/d to 35,000 m³/d. Also the inflow load of the steroid 
hormones rose during this period. 
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The effluent loads of the final settling tanks were in the same range as the effluent loads of the 
tertiary ponds. Generally these effluent loads are shifted, because the tertiary ponds holds a 
volume of 9,600 m³ which is a hydraulic retention time of one day. 
 
As an example for all steroid hormones the daily loads of estrone and hydroxyestrone during 
the sampling period are presented in Figure 41 and Figure 42. 
The concentrations ranged from 14 - 87 ng/L for estrone, 15 – 190 ng/L for hydroxyestrone, 
up to 18 ng/L for estradiol, 440 ng/L maximal for estriol, up to 26 ng/L for estrone 3-sulfate 
and <LOD – 28 ng/L for β-estradiol 3-sulfate in influents. The effluents had generally lower 
concentrations except for β-estradiol 3-sulfate. The maximal concentration of one examined 
steroid hormone was 140 ng/L in effluents.  
 
Figure 41: Daily loads of estrone in the inflow and the effluent of STP 3 as well as the 
effluent of the settling tank over the sampling period. Additionally the wastewater flow-rate 
during the sampling period is presented. 
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Figure 42: Daily loads of hydroxyestrone in the inflow and the effluent of STP 3 as well as 
the effluent of the settling tank over the sampling period. Additionally the wastewater flow-
rate during the sampling period is presented. 
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By comparing the loads of the influents with the load of the effluents, an elimination rate was 
calculated (Table 32). The elimination of the hormones ranged from 30 % – 82 %, except for 
β-estradiol 3-sulfate. This hormone conjugate shows no significant elimination during 
wastewater treatment. This could be explained by the assumption that other conjugates like 
disulfates and sulfate-glucuronides which were not measured, were transformed to β-estradiol 
3-sulfate during the wastewater treatment. Also a transformation of estrone 3-sulfate and 
other hormone-sulfates to β-estradiol 3-sulfate is possible. 
 
The elimination rates of estrone (Figure 43) and hydroxyestrone (Figure 44) as examples for 
all hormones, except from β-estradiol 3-sulfate, show a dependency on the flow-rate. The 
sampling in the first 22 days was during a dry weather period, the elimination rates varied 
extremely from 20% to 80 % for estrone while they were nearly constant for hydroxyestrone 
(75% to 95 %). Perhaps the STP is too small for a continuous stable elimination of the steroid 
hormones. 
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Figure 43: Elimination rates of estrone in STP 3 during the sampling period in comparison to 
the wastewater flow-rate. 
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Figure 44: Elimination rates of hydroxyestrone in STP 3 during the sampling period in 
comparison to the wastewater flow-rate. 
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Antibiotics 
The 24-h characteristic curve of the antibiotics given in Figure 45 shows a dependency on the 
time of the day. While the flow-rate decreased about 50 % during the night, erythromycin 
decreased from 1.3 g/2h between 20-22 o’clock to 0.2 g/2h between 6-8 o’clock. All other 
macrolide antibiotics behave similar. This decreasing over night and increasing in the 
morning indicates that also the macrolide antibiotics stems from excretion by humans. The 
well known ‘pee-peak’ is also observable. 
Additionally, a 24-h flow controlled composite sampling is recommended for the 
determination of elimination rates for antibiotics.  
 
 
Figure 45: Two hours inflow load of three hormones over one day in STP 3 
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The daily inflow load of the macrolide antibiotics ranged from 0.4 g up to 14 g, while the 
concentrations ranged from 85 - 780 ng/L for erythromycin, 92 – 1,500 ng/L for 
clarithromycin and 25 - 94 ng/L for roxithromycin in influents. The effluents had maximal 
concentration of 830 ng/L (ERY), 520 ng/L (CLA) and 170 ng/L (ROX).  
As an example for all three macrolide antibiotics the daily loads of erythromycin during the 
sampling period are shown in Figure 46. 
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The macrolide antibiotics were not eliminated significantly in this STP during the sampling 
period. Thus, a smaller dimension of STPs with a simultaneous denitrification step does not 
help to eliminate macrolide antibiotics during wastewater treatment.  
 
Figure 46: Daily loads of erythromycin as an example for the macrolide antibiotics n the 
inflow and the effluent of STP 3 as well as the effluent of the settling tank over the sampling 
period. Additionally the wastewater flow-rate during the sampling period is presented. 
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4.2.3.4 Comparison of the three STPs 
By comparison of all investigated STPs, the differences between STP 2 and STP 1 are 
especially remarkable. STP 2 is equipped with a trickling filter and serves only 64,000 
inhabitant equivalent values (IEV) while the more modern STP 1 handles 250,000 IEV (Table 
33). This comparison showed that the amount of steroid hormones released into the 
environment per day is up to a factor 6 higher in the smaller STP 2 than in the activated 
sludge plant (STP 1). 
 
No significant elimination for the macrolide antibiotics could be detected in any of the three 
STPs of this project. The daily discharge of these compounds raises up as expected with the 
number of affiliated persons (Table 33). 
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Table 33: Comparison of the daily discharge of steroid hormones and macrolide antibiotics in 
the three investigated STPs and inhabitant equivalent values (IEV) 
STP 1 
(250.000) IEV 
STP 2 
(64.000) IEV 
STP 3 
(32.000) IEV 
 
Discharge [mg/d] Discharge [mg/d] Discharge [mg/d] 
Estrone 253 1578 280 
16 α-Hydroxyestrone 414 394 111 
17β-Estradiol 340 288 84 
Estriol 2098 3215 358 
Estrone 3-sulfate 271 764 28 
β-Estradiol 3-sulfate 512 393 268 
Erythromycin 14555 3087 2750 
Clarithromycin 8770 4419 3679 
Roxithromycin 4618 1917 1282 
 
4.2.4 Conclusions to the fate of hormones and antibiotics in 
wastewater 
It has been demonstrated that steroid hormones and macrolide antibiotics were released into 
the environment via the pathway human, urine, wastewater, sewage treatment plant and 
effluents of STPs. Three different concepts of STPs were investigated to determine their 
elimination rates.  
Larger STPs eliminate hormones more constantly than small STPs. Heavy rainfall events, 
which resulted in high wastewater flow-rates, led to a collapse of the biological treatment 
concerning these compounds. More rain storage basins are necessary to reduce these influence 
on the wastewater treatment process. 
By means of the trickling filter technique the steroid hormones could not be eliminate during 
the wastewater treatment. Only a transformation of the hormones among each other was 
observed. This technique should be replaced with more state of the art treatment techniques.  
No significant elimination for the macrolide antibiotics could be detected in all three STPs. 
New concepts of treatment should be developed for the elimination of macrolide antibiotics 
during wastewater treatment if environmental issues were taken into consideration. 
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5 Overall Conclusions 
It has been demonstrated that two pathways of pharmaceuticals are prevalent in the 
environment. Path A starts with the application of human medical drugs, the excretion of 
drugs and transport via the sewer to sewage treatment plants. Finally the elimination of the 
pharmaceuticals in sewage treatment plants and discharging the treated water into the 
environment. A precise and robust analytical method in compliance within EU decision 
657/2002/EC was established for the determination of macrolide antibiotics, steroid 
hormones, hormone conjugates and oral contraceptives in heavily matrix loaded water. The 
investigation of the elimination efficiency of municipal sewage treatment plants has shown, 
that there is a release of high amounts of antibiotics and hormones into the environment. The 
elimination efficiency is also dependent on the actual weather condition. Heavy rainfall events 
can reduce the elimination of pharmaceuticals in a STP. It was also demonstrated that old 
treatment techniques like trickling filters were not able to eliminate these ‘new’ pollutions. 
The second path describes the application of veterinary drugs used for the prevention and 
treatment of infections in animal husbandry. The applied pharmaceuticals are excreted and 
transferred with the manure to manure tanks. During the storage of manure for several months 
the excreted pharmaceuticals undergo diverse transformation and degradation processes or 
remain unchanged in the manure. In a degradation experiment it was demonstrated that 
tiamulin persists in liquid manure while salinomycin was degraded rapidly. Several 
metabolites of salinomycin were identified during this manure degradation experiment. Two 
times in a year, fields are fertilised with liquid manure. The soil will be contaminated with the 
pharmaceuticals that are contained in the manure. It was demonstrated that soil, taken from 
fields which were fertilised with liquid manure containing antibiotics, had high amounts of 
antibiotics in the surface layer, as well as several months after fertilising. A degradation 
experiment of antibiotics in soil with similar aerobic field conditions affirmed these field 
sampling results that antibiotics persist in the environment. 
This work contributed significantly to the understanding of the environmental occurrence and 
fate of antibiotics and estrogenic hormones. 
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6 Used equipment and analytical standards 
6.1 Equipment 
6.1.1 Mass Spectrometer 
TSQ 7000 with APCI-2 and ESI-2 ion source (Finnigan MAT, Bremen, Germany) 
API 2000 with Heated Nebulizer and TurboIon Spray (Applied Biosystems, Darmstadt, 
Germany) 
Bio TOF III with ESI multispray ion source (Bruker, Bremen, Germany) 
 
6.1.2 HPLC 
6.1.2.1 Pump 
P 580 HPG binary high pressure gradient pump (Dionex, Idstein, Germany) 
LC-10 AT isocratic pump (Shimadzu, Duisburg, Germany) 
G1312A binary high pressure gradient pump with solvent selector (Agilent, Waldbronn, 
Germany) 
G1312A binary high pressure gradient pump (Agilent, Waldbronn, Germany) 
G1311A quaternary low pressure gradient pump (Agilent, Waldbronn, Germany) 
 
6.1.2.2 Autosampler 
Gina 50 (Dionex, Idstein, Germany) 
G1313A (Agilent, Waldbronn, Germany) 
 
6.1.2.3 Degasser 
DG-1210 (Dionex, Idstein, Germany) 
G1379A (Agilent, Waldbronn, Germany) 
G1322A (Agilent, Waldbronn, Germany) 
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6.1.2.4 Column Oven 
STH (Dionex, Idstein, Germany) 
G1316A with column selector (Agilent, Waldbronn, Germany) 
 
6.1.2.5 HPLC Column 
Phenosphere Next 3 µm, C18 (2) 150 x 2 mm (Phenomenex, Torrance CA, United States) 
Synergi RP-Max 4 µm, 150 x 2 mm (Phenomenex, Torrance CA, United States) 
Phenogel SEC column 5 µm, 100 Å, 21.2 x 300 mm (Phenomenex, Torrance CA, United 
States) 
6.1.3 Valve 
C2-2006D automatic valco valve (VICI AG, Schenkon, Switzerland)  
 
6.1.4 Evaporator 
Laborota 4001 with Rotavac Control (Heidolph, Kelheim, Germany) 
Büchi Syncore® Analyst 12 port evaporation unit (Büchi, Essen, Germany) 
 
6.1.5 Extractor 
ASE® 200 (Dionex, Idstein, Germany) 
 
6.1.6 Software 
Chromeleon Vers. 6.00 (Dionex, Idstein, Germany) 
ICL Vers. 8.3.2 (Thermo Electron Corporation, West Palm Beach FL, United States) 
XcaliburTM Vers. 1.2 (Thermo Electron Corporation, West Palm Beach FL, United States) 
XcaliburTM Vers. 1.3 (Thermo Electron Corporation, West Palm Beach FL, United States) 
Analyst 1.4 (Applied Biosystems, Darmstadt, Germany) 
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6.2 Analytical Standards 
 
Clarithromycin (Promochem, Wesel, Germany). 
Erythromycin, 98% (Sigma-Aldrich, Seelze, Germany) 
17β-Estradiol hemihydrate, VetranalTM, (Riedel-de Haën, Seelze, Germany) 
β-Estradiol 17-acetate, VetranalTM, (Riedel-de Haën, Seelze, Germany) 
β-Estradiol 3-sulfate sodium salt, (Sigma-Aldrich, Seelze, Germany) 
Estriol, (Sigma-Aldrich, Seelze, Germany) 
Estrone, (Sigma-Aldrich, Seelze, Germany) 
Estrone 2,4,16,16 - d4, (Sigma-Aldrich, Seelze, Germany) 
Estrone 3-sulfate potassium salt, (Sigma-Aldrich, Seelze, Germany) 
Estrone 3-sulfate 2,4,16,16 - d4 sodium salt (Dr. Ehrenstorfer GmbH, Augsburg, Germany) 
17α-Ethinylestradiol, VetranalTM, (Riedel-de Haën, Seelze, Germany) 
17α-Ethinylestradiol 2,4,16,16 - d4 (Dr. Ehrenstorfer GmbH, Augsburg, Germany) 
16α-Hydroxyestrone, (Sigma-Aldrich, Seelze, Germany) 
Ivermectin, main compound B1a (Sigma-Aldrich, Seelze, Germany) 
Roxithromycin, 90 % HPLC, (Sigma-Aldrich, Seelze, Germany) 
Salinomycin SV sodium salt, 83.2 % HPLC, , VetranalTM, (Riedel-de Haën, Seelze, Germany) 
Mestranol, VetranalTM, (Riedel-de Haën, Seelze, Germany) 
Monensin sodium salt, 89.6 % HPLC, , VetranalTM, (Riedel-de Haën, Seelze, Germany) 
Oleandomycinphosphatedihydrate, 86.2 % HPLC, VetranalTM, (Riedel-de Haën, Seelze, 
Germany) 
Tiamulinfumarate, 99.9 % HPLC, VetranalTM, (Riedel-de Haën, Seelze, Germany) 
Tylosintartrate, 918 µg Tylosin base per 1 mg Tylosintatrat, (Sigma-Aldrich, Seelze, 
Germany) 
 
 
Solvents were used as described in the respective chapters. 
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Table I: Date of sampling, flow rate and influent and effluent concentration and load of 
erythromycin in STP 1. 
 
STP 1 Erythromycin 
Concentration [ng/L] Load [g/d] 
Date Flow-rate [m³/d] Influent Effluent Influent Effluent 
31.08.04 75579 32 160 2.4 12 
01.09.04 42585 49 180 2.1 7.6 
02.09.04 40910 39 130 1.6 5.3 
03.09.04 40751 51 150 2.1 6.1 
04.09.04 41171 58 180 2.4 7.4 
05.09.04 39362 95 240 3.8 9.6 
06.09.04 43254 85 200 3.7 8.7 
07.09.04 41523 160 290 6.7 12 
08.09.04 40899 71 300 2.9 12 
09.09.04 40697 87 360 3.5 15 
10.09.04 39940 150 360 6.1 14 
11.09.04 124737 100 460 13 57 
12.09.04 49420 94 300 4.7 15 
13.09.04 40835 180 180 7.3 7.2 
14.09.04 41371 37 290 1.5 12 
15.09.04 41231 1200 320 49 13 
16.09.04 37846 1100 310 42 12 
17.09.04 37722 1100 260 40 9.8 
18.09.04 37019 1500 280 56 10 
19.09.04 51808 990 330 51 17 
20.09.04 43370 600 340 26 15 
21.09.04 61798 400 320 25 20 
22.09.04 150538 850 270 128 41 
23.09.04 177322 58 190 10 34 
24.09.04 96396 97 66 9.4 6.3 
25.09.04 57588 42 120 2.4 6.8 
26.09.04 52028 140 150 7.1 7.9 
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Table II: Date of sampling, flow rate and influent and effluent concentration and load of 
clarithromycin in STP 1. 
 
STP 1 Clarithromycin 
Concentration [ng/L] Load [g/d] 
Date Flow-rate [m³/d] Influent Effluent Influent Effluent 
31.08.04 75579 20 83 1.5 6.2 
01.09.04 42585 32 99 1.4 4.2 
02.09.04 40910 26 74 1.1 3.0 
03.09.04 40751 40 89 1.6 3.6 
04.09.04 41171 62 100 2.6 4.2 
05.09.04 39362 100 110 4.0 4.4 
06.09.04 43254 77 120 3.3 5.0 
07.09.04 41523 78 140 3.2 5.9 
08.09.04 40899 76 140 3.1 5.7 
09.09.04 40697 67 160 2.7 6.6 
10.09.04 39940 87 190 3.5 7.7 
11.09.04 124737 110 200 14 24 
12.09.04 49420 58 170 2.9 8.1 
13.09.04 40835 150 110 5.9 4.3 
14.09.04 41371 11 180 0.4 7.4 
15.09.04 41231 300 190 12 7.8 
16.09.04 37846 260 190 9.8 7.2 
17.09.04 37722 760 220 29 8.4 
18.09.04 37019 360 250 13 9.1 
19.09.04 51808 200 240 10 12 
20.09.04 43370 420 250 18 11 
21.09.04 61798 250 240 15 15 
22.09.04 150538 170 180 26 27 
23.09.04 177322 39 110 6.9 19 
24.09.04 96396 67 67 6.5 6.5 
25.09.04 57588 51 110 2.9 6.1 
26.09.04 52028 110 130 5.9 6.6 
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Table III: Date of sampling, flow rate and influent and effluent concentration and load of 
roxithromycin in STP 1. 
 
STP 1 Roxithromycin 
Concentration [ng/L] Load [g/d] 
Date Flow-rate [m³/d] Influent Effluent Influent Effluent 
31.08.04 75579 12 52 0.9 3.9 
01.09.04 42585 25 65 1.1 2.8 
02.09.04 40910 16 50 0.6 2.0 
03.09.04 40751 22 60 0.9 2.4 
04.09.04 41171 51 66 2.1 2.7 
05.09.04 39362 57 78 2.2 3.1 
06.09.04 43254 74 79 3.2 3.4 
07.09.04 41523 47 90 2.0 3.7 
08.09.04 40899 26 91 1.0 3.7 
09.09.04 40697 17 90 0.7 3.6 
10.09.04 39940 51 92 2.0 3.7 
11.09.04 124737 83 89 10 11 
12.09.04 49420 29 75 1.4 3.7 
13.09.04 40835 71 47 2.9 1.9 
14.09.04 41371 120 73 5.0 3.0 
15.09.04 41231 120 81 5.0 3.3 
16.09.04 37846 140 89 5.2 3.4 
17.09.04 37722 120 120 4.6 4.3 
18.09.04 37019 160 110 5.7 4.0 
19.09.04 51808 150 120 7.6 6.1 
20.09.04 43370 95 130 4.1 5.5 
21.09.04 61798 130 130 7.9 7.7 
22.09.04 150538 82 99 12 15 
23.09.04 177322 30 60 5.3 11 
24.09.04 96396 41 29 3.9 2.8 
25.09.04 57588 54 55 3.1 3.1 
26.09.04 52028 67 74 3.5 3.8 
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Table IV: Date of sampling, flow rate and influent and effluent concentration and load of β-
estradiol 3-sulfate in STP 1. 
 
STP 1 β-Estradiol 3-sulfate 
Concentration [ng/L] Load [g/d] 
Date Flow-rate [m³/d] Influent Effluent Influent Effluent 
31.08.04 75579 8.5-28* 7.1 2.1 0.5 
01.09.04 42585 <LOD 0.6-1.8* 0.4 0.1 
02.09.04 40910 <LOD 3.4 0.3 0.1 
03.09.04 40751 <LOD 0.6-1.8* 0.3 0.1 
04.09.04 41171 <LOD 5.6 0.3 0.2 
05.09.04 39362 <LOD 0.6-1.8* 0.3 0.1 
06.09.04 43254 <LOD 0.6-1.8* 0.4 0.1 
07.09.04 41523 <LOD 7.2 0.4 0.3 
08.09.04 40899 <LOD 0.6-1.8* 0.3 0.1 
09.09.04 40697 8.5-28* 14.0 1.1 0.6 
10.09.04 39940 8.5-28* 0.6-1.8* 1.1 0.1 
11.09.04 124737 <LOD 0.6-1.8* 1.1 0.2 
12.09.04 49420 8.5-28* 7.1 1.4 0.4 
13.09.04 40835 <LOD 4.7 0.3 0.2 
14.09.04 41371 <LOD 3.5 0.4 0.1 
15.09.04 41231 8.5-28* 6.5 1.2 0.3 
16.09.04 37846 8.5-28* 36 1.1 1.4 
17.09.04 37722 8.5-28* 3.1 1.1 0.1 
18.09.04 37019 8.5-28* 15 1.0 0.5 
19.09.04 51808 8.5-28* 9.4 1.5 0.5 
20.09.04 43370 8.5-28* 16 1.2 0.7 
21.09.04 61798 8.5-28* <LOD 1.7 0.0 
22.09.04 150538 <LOD 3.0 1.3 0.5 
23.09.04 177322 <LOD 3.6 1.5 0.6 
24.09.04 96396 <LOD 37 0.8 3.6 
25.09.04 57588 <LOD 12 0.5 0.7 
26.09.04 52028 <LOD 35 0.4 1.8 
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Table V: Date of sampling, flow rate and influent and effluent concentration and load of 
estrone 3-sulfate in STP 1. 
 
STP 1 Estrone 3-sulfate 
Concentration [ng/L] Load [g/d] 
Date Flow-rate [m³/d] Influent Effluent Influent Effluent 
31.08.04 75579 5.5 1.2 0.4 0.1 
01.09.04 42585 1.2-4* 1.0 0.2 0.0 
02.09.04 40910 1.2-4* 0.9 0.2 0.0 
03.09.04 40751 <LOD 0.7 0.0 0.0 
04.09.04 41171 <LOD 1.1 0.0 0.0 
05.09.04 39362 <LOD 1.5 0.0 0.1 
06.09.04 43254 <LOD 0.7 0.1 0.0 
07.09.04 41523 1.2-4* 5.1 0.0 0.2 
08.09.04 40899 <LOD 8.3 0.0 0.3 
09.09.04 40697 4.2 7.5 0.2 0.3 
10.09.04 39940 10 1.2 0.4 0.0 
11.09.04 124737 1.2-4* <LOD 0.5 0.1 
12.09.04 49420 1.2-4* 2.7 0.2 0.1 
13.09.04 40835 1.2-4* 4.5 0.2 0.2 
14.09.04 41371 <LOD 12 0.0 0.5 
15.09.04 41231 12 7.8 0.5 0.3 
16.09.04 37846 <LOD 12 0.0 0.5 
17.09.04 37722 8.1 13 0.3 0.5 
18.09.04 37019 17 12 0.6 0.5 
19.09.04 51808 9.3 9.4 0.5 0.5 
20.09.04 43370 10 <LOD 0.4 0.0 
21.09.04 61798 10 9.7 0.6 0.6 
22.09.04 150538 7.3 1.3 1.1 0.2 
23.09.04 177322 <LOD 3.1 0.2 0.5 
24.09.04 96396 8.4 7.8 0.8 0.8 
25.09.04 57588 1.2-4* 9.8 0.2 0.6 
26.09.04 52028 10 6.1 0.5 0.3 
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Table VI: Date of sampling, flow rate and influent and effluent concentration and load of 
estriol in STP 1. 
 
STP 1 Estriol 
Concentration [ng/L] Load [g/d] 
Date Flow-rate [m³/d] Influent Effluent Influent Effluent 
31.08.04 75579 101 45 7.7 3.4 
01.09.04 42585 12-35* 97 1.5 4.1 
02.09.04 40910 220 160 8.8 6.7 
03.09.04 40751 12-35* 4.5-15* 1.4 0.6 
04.09.04 41171 <LOD 120 0.5 5.0 
05.09.04 39362 12-35* 4.5-15* 1.4 0.6 
06.09.04 43254 44 4.5-15* 1.9 0.6 
07.09.04 41523 89 37 3.7 1.5 
08.09.04 40899 36 4.5-15* 1.5 0.6 
09.09.04 40697 12-35* 4.5-15* 1.4 0.6 
10.09.04 39940 84 4.5-15* 3.4 0.6 
11.09.04 124737 12-35* 32 4.4 4.0 
12.09.04 49420 124 82 6.1 4.1 
13.09.04 40835 12-35* 4.5-15* 1.4 0.6 
14.09.04 41371 <LOD <LOD 0.5 0.2 
15.09.04 41231 470 99 19 4.1 
16.09.04 37846 510 130 19 4.8 
17.09.04 37722 150 <LOD 5.8 0.2 
18.09.04 37019 200 66 7.5 2.4 
19.09.04 51808 68 4.5-15* 3.5 0.8 
20.09.04 43370 67 4.5-15* 2.9 0.7 
21.09.04 61798 130 76 8.0 4.7 
22.09.04 150538 66 <LOD 9.9 0.7 
23.09.04 177322 12-35* <LOD 6.2 0.8 
24.09.04 96396 12-35* <LOD 3.4 0.4 
25.09.04 57588 12-35* <LOD 2.0 0.3 
26.09.04 52028 12-35* 70 1.8 3.6 
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Table VII: Date of sampling, flow rate and influent and effluent concentration and load of 
16a-hydroxyestrone in STP 1. 
 
STP 1 16α-Hydroxyestrone 
Concentration [ng/L] Load [g/d] 
Date Flow-rate [m³/d] Influent Effluent Influent Effluent 
31.08.04 75579 15 <LOD 1.1 0.2 
01.09.04 42585 16 <LOD 0.7 0.1 
02.09.04 40910 17 <LOD 0.7 0.1 
03.09.04 40751 19 <LOD 0.8 0.1 
04.09.04 41171 21 <LOD 0.8 0.1 
05.09.04 39362 26 <LOD 1.0 0.1 
06.09.04 43254 13 <LOD 0.6 0.1 
07.09.04 41523 18 <LOD 0.7 0.1 
08.09.04 40899 14 <LOD 0.6 0.1 
09.09.04 40697 20 <LOD 0.8 0.1 
10.09.04 39940 11 <LOD 0.5 0.1 
11.09.04 124737 14 <LOD 1.7 0.3 
12.09.04 49420 23 <LOD 1.1 0.1 
13.09.04 40835 13 2.4-8* 0.5 0.3 
14.09.04 41371 2.4-8* <LOD 0.3 0.1 
15.09.04 41231 95 2.4-8* 3.9 0.3 
16.09.04 37846 73 14 2.8 0.5 
17.09.04 37722 105 17 3.9 0.6 
18.09.04 37019 32 12 1.2 0.4 
19.09.04 51808 35 2.4-8* 1.8 0.4 
20.09.04 43370 53 2.4-8* 2.3 0.3 
21.09.04 61798 29 2.4-8* 1.8 0.5 
22.09.04 150538 19 14 2.9 2.1 
23.09.04 177322 11 14 2.0 2.5 
24.09.04 96396 2.4-8* 2.4-8* 0.8 0.8 
25.09.04 57588 2.4-8* 2.4-8* 0.5 0.5 
26.09.04 52028 <LOD <LOD 0.1 0.1 
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Table VIII: Date of sampling, flow rate and influent and effluent concentration and load of 
17β-estradiol in STP 1. 
 
STP 1 17β-Estradiol 
Concentration [ng/L] Load [g/d] 
Date Flow-rate [m³/d] Influent Effluent Influent Effluent 
31.08.04 75579 46 <LOD 3.5 0.2 
01.09.04 42585 40 <LOD 1.7 0.1 
02.09.04 40910 43 <LOD 1.8 0.1 
03.09.04 40751 42 <LOD 1.7 0.1 
04.09.04 41171 52 <LOD 2.1 0.1 
05.09.04 39362 68 <LOD 2.7 0.1 
06.09.04 43254 41 <LOD 1.8 0.1 
07.09.04 41523 27 2.4-8* 1.1 0.3 
08.09.04 40899 14 <LOD 0.6 0.1 
09.09.04 40697 22 <LOD 0.9 0.1 
10.09.04 39940 13 <LOD 0.5 0.1 
11.09.04 124737 17 <LOD 2.2 0.3 
12.09.04 49420 9.2 <LOD 0.5 0.1 
13.09.04 40835 17 <LOD 0.7 0.1 
14.09.04 41371 <LOD <LOD 0.1 0.1 
15.09.04 41231 12 <LOD 0.5 0.1 
16.09.04 37846 17 8.4 0.7 0.3 
17.09.04 37722 23 12 0.9 0.5 
18.09.04 37019 34 2.4-8* 1.3 0.3 
19.09.04 51808 40 2.4-8* 2.1 0.4 
20.09.04 43370 36 2.4-8* 1.6 0.3 
21.09.04 61798 16 8.9 1.0 0.5 
22.09.04 150538 11 8.4 1.6 1.3 
23.09.04 177322 12 2.4-8* 2.2 1.4 
24.09.04 96396 22 2.4-8* 2.1 0.8 
25.09.04 57588 22 19 1.3 1.1 
26.09.04 52028 <LOD <LOD 0.1 0.1 
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Table IX: Date of sampling, flow rate and influent and effluent concentration and load of 
estrone in STP 1. 
 
STP 1 Estrone 
Concentration [ng/L] Load [g/d] 
Date Flow-rate [m³/d] Influent Effluent Influent Effluent 
31.08.04 75579 80 7.3 6.1 0.6 
01.09.04 42585 45 3.4 1.9 0.1 
02.09.04 40910 83 4.3 3.4 0.2 
03.09.04 40751 61 3.7 2.5 0.2 
04.09.04 41171 47 3.1 1.9 0.1 
05.09.04 39362 65 2.1 2.6 0.1 
06.09.04 43254 60 <LOD 2.6 0.0 
07.09.04 41523 82 4.6 3.4 0.2 
08.09.04 40899 44 0.6-2* 1.8 0.1 
09.09.04 40697 73 3.5 3.0 0.1 
10.09.04 39940 57 2.8 2.3 0.1 
11.09.04 124737 55 0.6-2* 6.8 0.2 
12.09.04 49420 40 <LOD 2.0 0.0 
13.09.04 40835 47 4.9 1.9 0.2 
14.09.04 41371 70 <LOD 2.9 0.0 
15.09.04 41231 92 <LOD 3.8 0.0 
16.09.04 37846 59 <LOD 2.2 0.0 
17.09.04 37722 130 <LOD 4.9 0.0 
18.09.04 37019 38 <LOD 1.4 0.0 
19.09.04 51808 37 <LOD 1.9 0.0 
20.09.04 43370 57 <LOD 2.5 0.0 
21.09.04 61798 67 <LOD 4.2 0.0 
22.09.04 150538 45 <LOD 6.7 0.0 
23.09.04 177322 19 <LOD 3.3 0.0 
24.09.04 96396 34 0.6-2* 3.3 0.1 
25.09.04 57588 38 58 2.2 0.0 
26.09.04 52028 51 13 2.6 0.7 
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Table X: Date of sampling, flow rate and influent and effluent concentration and load of 
erythromycin in STP 2. 
 
STP 2 Erythromycin 
Concentration [ng/L] Load [g/d] 
Date Flow-rate [m³/d] Influent Effluent Influent Effluent 
28.02.05 10795 210 290 2.2 3.1 
01.03.05 9695 420 250 4.1 2.4 
02.03.05 9908 440 340 4.4 3.4 
03.03.05 9708 650 360 6.3 3.4 
04.03.05 9062 360 350 3.3 3.2 
05.03.05 8713 560 370 4.9 3.3 
06.03.05 8118 320 340 2.6 2.8 
07.03.05 13332 250 440 3.3 5.9 
08.03.05 17474 180 290 3.1 5.1 
09.03.05 17943 170 210 3.0 3.7 
10.03.05 14675 160 180 2.3 2.6 
11.03.05 23874 130 150 3.0 3.7 
12.03.05 31214 88 90 2.7 2.8 
13.03.05 31413 73 60 2.3 1.9 
14.03.05 23829 120 87 2.9 2.1 
15.03.05 18610 190 130 3.4 2.3 
16.03.05 18880 140 170 2.6 3.1 
17.03.05 21269 160 120 3.5 2.6 
18.03.05 23865 120 130 2.9 3.1 
19.03.05 24391 140 200 3.3 5.0 
20.03.05 20040 97 130 1.9 2.7 
21.03.05 18890 130 120 2.5 2.2 
22.03.05 16082 104 140 2.2 2.2 
30.03.05 18225 79 90 1.4 1.6 
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Table XI: Date of sampling, flow rate and influent and effluent concentration and load of 
clarithromycin in STP 2. 
 
STP 2 Clarithromycin 
Concentration [ng/L] Load [g/d] 
Date Flow-rate [m³/d] Influent Effluent Influent Effluent 
28.02.05 10795 330 390 3.6 4.3 
01.03.05 9695 690 390 6.7 3.8 
02.03.05 9908 490 460 4.8 4.6 
03.03.05 9708 440 440 4.3 4.3 
04.03.05 9062 500 400 4.6 3.6 
05.03.05 8713 400 400 3.6 3.5 
06.03.05 8118 450 450 3.6 3.7 
07.03.05 13332 370 480 4.9 6.4 
08.03.05 17474 310 380 5.4 6.6 
09.03.05 17943 330 310 5.9 5.6 
10.03.05 14675 420 290 6.2 4.2 
11.03.05 23874 170 320 4.2 7.7 
12.03.05 31214 130 170 4.1 5.4 
13.03.05 31413 140 120 4.4 3.7 
14.03.05 23829 190 160 4.5 3.7 
15.03.05 18610 220 210 4.1 3.9 
16.03.05 18880 180 210 3.4 4.0 
17.03.05 21269 170 160 3.6 3.4 
18.03.05 23865 140 150 3.3 3.4 
19.03.05 24391 160 300 3.8 7.4 
20.03.05 20040 190 180 3.8 3.5 
21.03.05 18890 280 200 5.2 3.7 
22.03.05 16082 190 240 3.1 3.9 
30.03.05 18225 97 100 1.8 1.9 
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Table XII: Date of sampling, flow rate and influent and effluent concentration and load of 
roxithromycin in STP 2. 
 
STP 2 Roxithromycin 
Concentration [ng/L] Load [g/d] 
Date Flow-rate [m³/d] Influent Effluent Influent Effluent 
28.02.05 10795 160 150 1.8 1.6 
01.03.05 9695 230 150 2.2 1.4 
02.03.05 9908 190 190 1.8 1.9 
03.03.05 9708 210 220 2.1 2.2 
04.03.05 9062 250 240 2.2 2.2 
05.03.05 8713 180 240 1.6 2.1 
06.03.05 8118 250 270 2.0 2.2 
07.03.05 13332 230 350 3.0 4.7 
08.03.05 17474 160 270 2.7 4.7 
09.03.05 17943 120 170 2.2 3.0 
10.03.05 14675 120 140 1.8 2.0 
11.03.05 23874 80 120 1.9 2.9 
12.03.05 31214 60 66 1.9 2.1 
13.03.05 31413 61 58 1.9 1.8 
14.03.05 23829 43 58 1.0 1.4 
15.03.05 18610 94 82 1.7 1.5 
16.03.05 18880 52 90 1.0 1.7 
17.03.05 21269 35 59 0.7 1.3 
18.03.05 23865 36 49 0.9 1.2 
19.03.05 24391 25 52 0.6 1.3 
20.03.05 20040 16 28 0.3 0.6 
21.03.05 18890 30 24 0.6 0.5 
22.03.05 16082 38 46 0.6 0.7 
30.03.05 18225 62 60 1.1 1.1 
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Table XIII: Date of sampling, flow rate and influent and effluent concentration and load of 
β-estradiol 3-sulfate in STP 2. 
 
STP 2 β-Estradiol 3-sulfate 
Concentration [ng/L] Load [mg/d] 
Date Flow-rate [m³/d] Influent Effluent Influent Effluent 
28.02.05 10795 <LOD 29 92 311 
01.03.05 9695 <LOD 22 82 217 
02.03.05 9908 <LOD 16 84 156 
03.03.05 9708 <LOD 36 83 346 
04.03.05 9062 <LOD 26 77 235 
05.03.05 8713 <LOD 32 74 283 
06.03.05 8118 8.5-28* 31 227 253 
07.03.05 13332 <LOD 52 113 689 
08.03.05 17474 <LOD 24 149 414 
09.03.05 17943 <LOD 29 153 515 
10.03.05 14675 <LOD 34 125 504 
11.03.05 23874 <LOD 39 203 936 
12.03.05 31214 <LOD 23 265 714 
13.03.05 31413 <LOD <LOD 267 57 
14.03.05 23829 <LOD 23 203 545 
15.03.05 18610 <LOD 24 158 451 
16.03.05 18880 <LOD 30 160 569 
17.03.05 21269 <LOD 14 181 298 
18.03.05 23865 8.5-28* <LOD 668 43 
19.03.05 24391 8.5-28* 23 683 565 
20.03.05 20040 8.5-28* 24 561 487 
21.03.05 18890 <LOD 12 161 221 
22.03.05 16082 <LOD 26 137 421 
30.03.05 18225 8.5-28* 10 510 187 
 
Supplement 
 N 
 
Table XIV: Date of sampling, flow rate and influent and effluent concentration and load of 
estrone3-sulfate in STP 2. 
 
STP 2 Estrone 3-sulfate 
Concentration [ng/L] Load [g/d] 
Date Flow-rate [m³/d] Influent Effluent Influent Effluent 
28.02.05 10795 12 44 0.1 0.5 
01.03.05 9695 11 41 0.1 0.4 
02.03.05 9908 11 60 0.1 0.6 
03.03.05 9708 15 68 0.1 0.7 
04.03.05 9062 19 61 0.2 0.6 
05.03.05 8713 13 62 0.1 0.5 
06.03.05 8118 14 66 0.1 0.5 
07.03.05 13332 9.3 73 0.1 1.0 
08.03.05 17474 7.7 58 0.1 1.0 
09.03.05 17943 8.3 47 0.1 0.9 
10.03.05 14675 9.8 49 0.1 0.7 
11.03.05 23874 5.8 53 0.1 1.3 
12.03.05 31214 6.2 31 0.2 1.0 
13.03.05 31413 4.1 23 0.1 0.7 
14.03.05 23829 6.5 37 0.2 0.9 
15.03.05 18610 5.5 45 0.1 0.8 
16.03.05 18880 8.3 44 0.2 0.8 
17.03.05 21269 10 47 0.2 1.0 
18.03.05 23865 6.5 42 0.2 1.0 
19.03.05 24391 19 51 0.5 1.2 
20.03.05 20040 6.5 38 0.1 0.8 
21.03.05 18890 11 33 0.2 0.6 
22.03.05 16082 11 37 0.2 0.6 
30.03.05 18225 18 17 0.3 0.3 
 
Supplement 
 O
 
Table XV: Date of sampling, flow rate and influent and effluent concentration and load of 
estriol in STP 2. 
 
STP 2 Estriol 
Concentration [ng/L] Load [g/d] 
Date Flow-rate [m³/d] Influent Effluent Influent Effluent 
28.02.05 10795 12-35* 4.5-15* 0.7 0.3 
01.03.05 9695 84 51 1.4 0.5 
02.03.05 9908 38 100 0.6 1.0 
03.03.05 9708 46 83 0.8 0.8 
04.03.05 9062 54 47 0.8 0.4 
05.03.05 8713 62 98 0.9 0.9 
06.03.05 8118 67 36 0.9 0.3 
07.03.05 13332 38 210 0.9 2.7 
08.03.05 17474 75 220 2.2 3.8 
09.03.05 17943 76 140 2.4 2.4 
10.03.05 14675 92 110 2.3 1.5 
11.03.05 23874 210 290 8.6 6.9 
12.03.05 31214 110 33 5.8 1.0 
13.03.05 31413 120 100 6.2 3.1 
14.03.05 23829 110 74 4.4 1.8 
15.03.05 18610 110 82 3.5 1.5 
16.03.05 18880 200 180 6.3 3.4 
17.03.05 21269 220 230 8.0 5.0 
18.03.05 23865 460 430 19 10 
19.03.05 24391 450 520 19 13 
20.03.05 20040 270 400 9.2 8.1 
21.03.05 18890 170 160 5.5 3.0 
22.03.05 16082 68 220 1.9 3.6 
30.03.05 18225 160 120 4.9 2.2 
 
Supplement 
 P
 
Table XVI: Date of sampling, flow rate and influent and effluent concentration and load of 
16α-hydroxyestrone in STP 2. 
 
STP 2 16α-Hydroxyestrone 
Concentration [ng/L] Load [g/d] 
Date Flow-rate [m³/d] Influent Effluent Influent Effluent 
28.02.05 10795 110 25 1.2 0.3 
01.03.05 9695 89 15 0.9 0.1 
02.03.05 9908 130 27 1.3 0.3 
03.03.05 9708 130 16 1.3 0.2 
04.03.05 9062 82 62 0.7 0.6 
05.03.05 8713 120 18 1.1 0.2 
06.03.05 8118 170 80 1.4 0.7 
07.03.05 13332 88 80 1.2 1.1 
08.03.05 17474 96 73 1.7 1.3 
09.03.05 17943 80 59 1.4 1.1 
10.03.05 14675 170 32 2.5 0.5 
11.03.05 23874 69 2.4-8* 1.6 0.0 
12.03.05 31214 48 20 1.5 0.6 
13.03.05 31413 26 15 0.8 0.5 
14.03.05 23829 57 25 1.4 0.6 
15.03.05 18610 86 <LOD 1.6 0.6 
16.03.05 18880 37 2.4-8* 0.7 0.0 
17.03.05 21269 33 2.4-8* 0.7 0.0 
18.03.05 23865 33 2.4-8* 0.8 0.0 
19.03.05 24391 2.4-8* 30 0.3 0.7 
20.03.05 20040 39 2.4-8* 0.8 0.0 
21.03.05 18890 30 2.4-8* 0.6 0.0 
22.03.05 16082 53 21 0.9 0.3 
30.03.05 18225 22 2.4-8* 0.4 0.0 
 
Supplement 
 Q
 
Table XVII: Date of sampling, flow rate and influent and effluent concentration and load of 
17β-estradiol in STP 2. 
 
STP 2 17β-Estradiol 
Concentration [ng/L] Load [mg/d] 
Date Flow-rate [m³/d] Influent Effluent Influent Effluent 
28.02.05 10795 2.4-8* 2.4-8* 86 86 
01.03.05 9695 2.4-8* 12 78 112 
02.03.05 9908 2.4-8* 15 79 152 
03.03.05 9708 2.4-8* 2.4-8* 78 78 
04.03.05 9062 <LOD 13 22 117 
05.03.05 8713 2.4-8* 17 70 151 
06.03.05 8118 2.4-8* 25 65 200 
07.03.05 13332 2.4-8* 2.4-8* 107 107 
08.03.05 17474 2.4-8* 14 140 140 
09.03.05 17943 13 35 239 636 
10.03.05 14675 13 11 188 161 
11.03.05 23874 9.0 25 215 588 
12.03.05 31214 2.4-8* 12 250 387 
13.03.05 31413 2.4-8* 14 251 425 
14.03.05 23829 8.1 18 194 438 
15.03.05 18610 18 23 326 432 
16.03.05 18880 10 32 197 609 
17.03.05 21269 17 2.4-8* 356 170 
18.03.05 23865 13 10 321 249 
19.03.05 24391 9.4 14 228 346 
20.03.05 20040 11 20 224 410 
21.03.05 18890 11 18 200 335 
22.03.05 16082 17 20 278 319 
30.03.05 18225 17 13 318 244 
 
Supplement 
 R
 
Table XVIII: Date of sampling, flow rate and influent and effluent concentration and load of 
estrone in STP 2. 
 
STP 2 Estrone 
Concentration [ng/L] Load [g/d] 
Date Flow-rate [m³/d] Influent Effluent Influent Effluent 
28.02.05 10795 33 67 0.4 0.7 
01.03.05 9695 68 95 0.7 0.9 
02.03.05 9908 49 101 0.5 1.0 
03.03.05 9708 52 79 0.5 0.8 
04.03.05 9062 68 65 0.6 0.6 
05.03.05 8713 60 89 0.5 0.8 
06.03.05 8118 43 174 0.4 1.4 
07.03.05 13332 45 49 0.6 0.7 
08.03.05 17474 52 96 0.9 1.7 
09.03.05 17943 59 114 1.0 2.1 
10.03.05 14675 80 99 1.2 1.4 
11.03.05 23874 47 157 1.1 3.8 
12.03.05 31214 45 88 1.4 2.7 
13.03.05 31413 18 73 0.6 2.3 
14.03.05 23829 38 105 0.9 2.5 
15.03.05 18610 102 99 1.9 1.8 
16.03.05 18880 69 129 1.3 2.4 
17.03.05 21269 53 36 1.1 0.8 
18.03.05 23865 37 60 0.9 1.4 
19.03.05 24391 55 93 1.4 2.3 
20.03.05 20040 61 90 1.2 1.8 
21.03.05 18890 49 77 0.9 1.5 
22.03.05 16082 71 79 1.1 1.3 
30.03.05 18225 53 70 1.0 1.3 
 
Supplement 
 S
 
Table XIX: Date of sampling, flow rate and influent and effluent concentration and load of 
erythromycin in STP 3. 
 
STP 3 Erythromycin 
Concentration [ng/L] Load [g/d] 
Date 
Flow-
rate 
[m³/d] Influent Sett.-tank Effluent Influent Sett.-tank Effluent 
06.06.05 9313 160 150 160 1.5 1.4 1.5 
07.06.05 12117 160  130 1.9  1.6 
08.06.05 10089 450  150 4.6  1.5 
09.06.05 10079 330 160 130 3.3 1.6 1.3 
10.06.05 11845 260  210 3.0  2.5 
11.06.05 10749 220  260 2.3  2.8 
12.06.05 9219 780  230 7.2  2.1 
13.06.05 10778 240 200 240 2.5 2.1 2.6 
14.06.05 9188 240  260 2.2  2.3 
15.06.05 8865 300  250 2.7  2.2 
16.06.05 6206 370 340 290 2.3 2.1 1.8 
17.06.05 9364 290  330 2.8  3.0 
18.06.05 8453 360  260 3.1  2.2 
19.06.05 7944 530  190 4.2  1.5 
20.06.05 8577 430 410 460 3.6 3.5 4.0 
21.06.05 8633 340  360 2.9  3.1 
22.06.05 8403 600  830 5.0  7.0 
23.06.05 8398 350 320 330 2.9 2.7 2.7 
24.06.05 10980 230  280 2.5  3.1 
25.06.05 8750 400  370 3.5  3.3 
26.06.05 7748 450  520 3.5  4.0 
27.06.05 8525 430 310 310 3.7 2.6 2.7 
28.06.05 7937 190  330 1.5  2.6 
29.06.05 16601 220  180 3.6  3.0 
30.06.05 33529 160 97 85 5.3 3.2 2.8 
01.07.05 33782 85  80 2.9  2.7 
02.07.05 23242 170  200 4.0  4.5 
03.07.05 13651 210 150 240 2.9 1.4 3.2 
 
Supplement 
 T
 
Table XX: Date of sampling, flow rate and influent and effluent concentration and load of 
clarithromycin in STP 3. 
 
STP 3 Clarithromycin 
Concentration [ng/L] Load [g/d] 
Date 
Flow-
rate 
[m³/d] Influent Sett.-tank Effluent Influent Sett.-tank Effluent 
06.06.05 9313 240 240 250 2.2 2.2 2.3 
07.06.05 12117 320  210 3.9  2.5 
08.06.05 10089 290  270 2.9  2.8 
09.06.05 10079 280 260 260 2.8 2.6 2.6 
10.06.05 11845 360  360 4.2  4.3 
11.06.05 10749 480  350 5.1  3.8 
12.06.05 9219 1500  300 14  2.8 
13.06.05 10778 430 390 470 4.7 4.2 5.0 
14.06.05 9188 300  470 2.8  4.3 
15.06.05 8865 430  480 3.8  4.3 
16.06.05 6206 520 440 480 3.2 2.7 3.0 
17.06.05 9364 490  510 4.6  4.8 
18.06.05 8453 390  480 3.3  4.1 
19.06.05 7944 220  520 1.8  4.1 
20.06.05 8577 240 350 450 2.1 3.0 3.8 
21.06.05 8633 240  500 2.0  4.3 
22.06.05 8403 230  440 1.9  3.7 
23.06.05 8398 130 300 390 1.1 2.5 3.2 
24.06.05 10980 210  360 2.3  4.0 
25.06.05 8750 160  340 1.4  3.0 
26.06.05 7748 160  360 1.2  2.8 
27.06.05 8525 190 230 330 1.6 1.9 2.8 
28.06.05 7937 93  310 0.7  2.5 
29.06.05 16601 98  290 1.6  4.7 
30.06.05 33529 92 89 190 3.1 3.0 6.5 
01.07.05 33782 150  160 5.1  5.3 
02.07.05 23242 370  160 8.7  3.6 
03.07.05 13651 350 240 190 4.8  2.6 
 
Supplement 
 U
 
Table XXI: Date of sampling, flow rate and influent and effluent concentration and load of 
roxithromycin in STP 3. 
 
STP 3 Roxithromycin 
Concentration [ng/L] Load [g/d] 
Date 
Flow-
rate 
[m³/d] Influent Sett.-tank Effluent Influent Sett.-tank Effluent 
06.06.05 9313 92 93 110 0.9 0.9 1.0 
07.06.05 12117 81  87 1.0  1.1 
08.06.05 10089 56  110 0.6  1.1 
09.06.05 10079 55 97 91 0.6 1.0 0.9 
10.06.05 11845 93  130 1.1  1.5 
11.06.05 10749 78  120 0.8  1.3 
12.06.05 9219 56  110 0.5  1.0 
13.06.05 10778 72 149 130 0.8 1.6 1.4 
14.06.05 9188 46  180 0.4  1.7 
15.06.05 8865 66  150 0.6  1.3 
16.06.05 6206 49 102 140 0.3 0.6 0.8 
17.06.05 9364 71  120 0.7  1.1 
18.06.05 8453 57  98 0.5  0.8 
19.06.05 7944 65  97 0.5  0.8 
20.06.05 8577 89 87 96 0.8 0.7 0.8 
21.06.05 8633 72  100 0.6  0.9 
22.06.05 8403 94  110 0.8  0.9 
23.06.05 8398 50 97 120 0.4 0.8 1.0 
24.06.05 10980 78  130 0.9  1.4 
25.06.05 8750 49  130 0.4  1.1 
26.06.05 7748 70  160 0.5  1.2 
27.06.05 8525 72 110 170 0.6 0.9 1.5 
28.06.05 7937 54  150 0.4  1.2 
29.06.05 16601 50  150 0.8  2.5 
30.06.05 33529 51 46 94 1.7 1.5 3.2 
01.07.05 33782 59  56 2.0  1.9 
02.07.05 23242 25  58 0.6  1.3 
03.07.05 13651 84 93 85 1.1 0.9 1.2 
 
Supplement 
 V 
 
Table XXII: Date of sampling, flow rate and influent and effluent concentration and load of 
β-estradiol 3-sulfate in STP 3. 
 
STP 3 β-Estradiol 3-sulfate 
Concentration [ng/L] Load [g/d] 
Date 
Flow-
rate 
[m³/d] Influent Sett.-tank Effluent Influent Sett.-tank Effluent 
06.06.05 9313 <LOD 5.8 14 0.1 0.1 0.1 
07.06.05 12117 <LOD  9.0 0.1  0.1 
08.06.05 10089 8.5-28*  14 0.3  0.1 
09.06.05 10079 8.5-28* 8.0 139 0.3 0.1 1.4 
10.06.05 11845 8.5-28*  90 0.3  1.1 
11.06.05 10749 <LOD  16 0.1  0.2 
12.06.05 9219 8.5-28*  13 0.3  0.1 
13.06.05 10778 8.5-28* <LOD 141 0.3 0.0 1.5 
14.06.05 9188 8.5-28*  9.9 0.3  0.1 
15.06.05 8865 32  29 0.3  0.3 
16.06.05 6206 8.5-28* 8.8 10 0.2 0.1 0.1 
17.06.05 9364 79  14 0.7  0.1 
18.06.05 8453 8.5-28*  12 0.2  0.1 
19.06.05 7944 <LOD  23 0.1  0.2 
20.06.05 8577 8.5-28* 6.8 5.6 0.2 0.1 0.0 
21.06.05 8633 33  13 0.3  0.1 
22.06.05 8403 8.5-28*  <LOD 0.2  0.0 
23.06.05 8398 8.5-28* 7.7 13 0.2 0.1 0.1 
24.06.05 10980 <LOD  5.2 0.1  0.1 
25.06.05 8750 8.5-28*  13 0.2  0.1 
26.06.05 7748 8.5-28*  14 0.2  0.1 
27.06.05 8525 8.5-28* 0.6-1.8* 6.8 0.2 0.0 0.1 
28.06.05 7937 <LOD  8.6 0.1  0.1 
29.06.05 16601 <LOD  15 0.1  0.2 
30.06.05 33529 8.5-28* 15.9 10 0.9 0.5 0.3 
01.07.05 33782 30  17 1.0  0.6 
02.07.05 23242 36  <LOD 0.8  0.0 
03.07.05 13651 25  13 0.3  0.2 
 
Supplement 
 W
 
Table XXIII: Date of sampling, flow rate and influent and effluent concentration and load of 
estrone 3-sulfate in STP 3. 
 
STP 3 Estrone 3-sulfate 
Concentration [ng/L] Load [mg/d] 
Date 
Flow-
rate 
[m³/d] Influent Sett.-tank Effluent Influent Sett.-tank Effluent 
06.06.05 9313 6.1 1.2 2.1 57 12 20 
07.06.05 12117 5.5  2.1 67  25 
08.06.05 10089 10  0.9 106  9 
09.06.05 10079 14 0.8 2.0 142 8 20 
10.06.05 11845 13  3.5 160  41 
11.06.05 10749 7.4  2.0 79  22 
12.06.05 9219 8.1  0.8 74  7 
13.06.05 10778 4.6 5.0 <LOD 50 54 5 
14.06.05 9188 12  2.9 111  27 
15.06.05 8865 9.3  9.3 82  82 
16.06.05 6206 15 3.0 3.0 93 19 18 
17.06.05 9364 26  3.4 242  32 
18.06.05 8453 8.6  4.6 73  39 
19.06.05 7944 6.9  6.2 55  49 
20.06.05 8577 9.8 2.6 3.7 84 22 32 
21.06.05 8633 16  4.9 137  43 
22.06.05 8403 14  4.3 116  36 
23.06.05 8398 16 <LOD 2.8 138 0 23 
24.06.05 10980 20  2.4 217  26 
25.06.05 8750 11  2.2 99  19 
26.06.05 7748 15  3.1 119  24 
27.06.05 8525 17 1.0 1.5 144 9 13 
28.06.05 7937 13  0.8 107  6 
29.06.05 16601 1.2-4*  5.8 66  97 
30.06.05 33529 <LOD <LOD <LOD 40 0 17 
01.07.05 33782 <LOD  <LOD 41 12 17 
02.07.05 23242 6.9  <LOD 160  12 
03.07.05 13651 <LOD 1.2 1.7 16  23 
 
Supplement 
 X 
 
Table XXIV: Date of sampling, flow rate and influent and effluent concentration and load of 
estriol in STP 3. 
 
STP 3 Estriol 
Concentration [ng/L] Load [g/d] 
Date 
Flow-
rate 
[m³/d] Influent Sett.-tank Effluent Influent Sett.-tank Effluent 
06.06.05 9313 61 4.5-15* 4.5-15* 0.6 0.1 0.1 
07.06.05 12117 12-35*  <LOD 0.4  0.1 
08.06.05 10089 161  <LOD 1.6  0.0 
09.06.05 10079 150 <LOD <LOD 1.6 0.0 0.0 
10.06.05 11845 94  32 1.1  0.4 
11.06.05 10749 170  <LOD 1.9  0.0 
12.06.05 9219 180  <LOD 1.7  0.0 
13.06.05 10778 12-35* 120 251 0.4 1.3 2.7 
14.06.05 9188 76  <LOD 0.7  0.0 
15.06.05 8865 70  <LOD 0.6  0.0 
16.06.05 6206 210 <LOD <LOD 1.3 0.0 0.0 
17.06.05 9364 440  4.5-15* 4.2  0.1 
18.06.05 8453 140  4.5-15* 1.1  0.1 
19.06.05 7944 12-35*  4.5-15* 0.3  0.1 
20.06.05 8577 12-35* <LOD <LOD 0.3 0.0 0.0 
21.06.05 8633 93  53 0.8  0.5 
22.06.05 8403 12-35*  <LOD 0.3  0.0 
23.06.05 8398 <LOD 86 4.5-15* 0.1 0.7 0.1 
24.06.05 10980 <LOD  <LOD 0.1  0.0 
25.06.05 8750 95  4.5-15* 0.8  0.1 
26.06.05 7748 12-35*  29 0.3  0.2 
27.06.05 8525 93 <LOD 4.5-15* 0.8 0.0 0.1 
28.06.05 7937 <LOD  62 0.1  0.5 
29.06.05 16601 12-35*  <LOD 0.6  0.1 
30.06.05 33529 12-35* 46 4.5-15* 1.2 1.5 0.5 
01.07.05 33782 100  104 3.5  3.5 
02.07.05 23242 12-35*  <LOD 0.8  0.1 
03.07.05 13651 390 4.5-15* 4.5-15* 5.3 0.1 0.2 
 
Supplement 
 Y
 
Table XXV: Date of sampling, flow rate and influent and effluent concentration and load of 
16α-hydroxyestrone in STP 3. 
 
STP 3 16α-Hydroxyestrone 
Concentration [ng/L] Load [g/d] 
Date 
Flow-
rate 
[m³/d] Influent Sett.-tank Effluent Influent Sett.-tank Effluent 
06.06.05 9313 53 2.4-8* 2.4-8* 0.5 0.0 0.1 
07.06.05 12117 31  2.4-8* 0.4  0.1 
08.06.05 10089 53  2.4-8* 0.5  0.1 
09.06.05 10079 50 2.4-8* <LOD 0.5 0.1 0.0 
10.06.05 11845 62  2.4-8* 0.7  0.1 
11.06.05 10749 46  2.4-8* 0.5  0.1 
12.06.05 9219 38  2.4-8* 0.3  0.1 
13.06.05 10778 33 2.4-8* 2.4-8* 0.4 0.1 0.1 
14.06.05 9188 53  2.4-8* 0.5  0.1 
15.06.05 8865 55  2.4-8* 0.5  0.1 
16.06.05 6206 37 2.4-8* 2.4-8* 0.2 0.0 0.0 
17.06.05 9364 42  2.4-8* 0.4  0.1 
18.06.05 8453 100  14 0.9  0.1 
19.06.05 7944 79  2.4-8* 0.6  0.1 
20.06.05 8577 190 2.4-8* 11 1.6 0.1 0.1 
21.06.05 8633 56  2.4-8* 0.5  0.1 
22.06.05 8403 68  2.4-8* 0.6  0.1 
23.06.05 8398 81 2.4-8* 14 0.7 0.1 0.1 
24.06.05 10980 89  2.4-8* 1.0  0.1 
25.06.05 8750 22  2.4-8* 0.2  0.1 
26.06.05 7748 62  2.4-8* 0.5  0.1 
27.06.05 8525 110 2.4-8* 2.4-8* 0.9 0.1 0.1 
28.06.05 7937 62  2.4-8* 0.5  0.1 
29.06.05 16601 63  17 1.1  0.3 
30.06.05 33529 15 12 2.4-8* 0.5 0.4 0.3 
01.07.05 33782 17  14 0.6  0.5 
02.07.05 23242 39  2.4-8* 0.9  0.2 
03.07.05 13651 49  2.4-8* 0.7  0.1 
 
Supplement 
 Z
 
Table XXVI: Date of sampling, flow rate and influent and effluent concentration and load of 
17β-estradiol in STP 3. 
 
STP 3 17β-Estradiol 
Concentration [ng/L] Load [g/d] 
Date 
Flow-
rate 
[m³/d] Influent Sett.-tank Effluent Influent Sett.-tank Effluent 
06.06.05 9313 2.4-8* <LOD 2.4-8* 0.1 0.0 0.1 
07.06.05 12117 <LOD  2.4-8* 0.0  0.1 
08.06.05 10089 8.5  <LOD 0.1  0.0 
09.06.05 10079 9.6 <LOD <LOD 0.1 0.0 0.0 
10.06.05 11845 11  <LOD 0.1  0.0 
11.06.05 10749 2.4-8*  <LOD 0.1  0.0 
12.06.05 9219 2.4-8*  2.4-8* 0.1  0.1 
13.06.05 10778 15 2.4-8* 2.4-8* 0.2 0.1 0.1 
14.06.05 9188 10  2.4-8* 0.1  0.1 
15.06.05 8865 2.4-8*  2.4-8* 0.1  0.1 
16.06.05 6206 9.5 2.4-8* 2.4-8* 0.1 0.0 0.0 
17.06.05 9364 14  <LOD 0.1  0.0 
18.06.05 8453 10  7.4 0.1  0.1 
19.06.05 7944 15  2.4-8* 0.1  0.1 
20.06.05 8577 18 2.4-8* 2.4-8* 0.2 0.1 0.1 
21.06.05 8633 12  2.4-8* 0.1  0.1 
22.06.05 8403 15  2.4-8* 0.1  0.1 
23.06.05 8398 2.4-8* 2.4-8* 2.4-8* 0.1 0.1 0.1 
24.06.05 10980 2.4-8*  2.4-8* 0.1  0.1 
25.06.05 8750 9.5  2.4-8* 0.1  0.1 
26.06.05 7748 15  2.4-8* 0.1  0.1 
27.06.05 8525 12 2.4-8* 2.4-8* 0.1 0.1 0.1 
28.06.05 7937 2.4-8*  2.4-8* 0.1  0.1 
29.06.05 16601 2.4-8*  2.4-8* 0.1  0.1 
30.06.05 33529 2.4-8* 2.4-8* 2.4-8* 0.3 0.3 0.3 
01.07.05 33782 2.4-8*  2.4-8* 0.3  0.3 
02.07.05 23242 2.4-8*  2.4-8* 0.2  0.2 
03.07.05 13651 10  2.4-8* 0.1 0.0 0.1 
 
Supplement 
 AA
 
Table XXVII: Date of sampling, flow rate and influent and effluent concentration and load of 
estrone in STP 3. 
 
STP 3 Estrone 
Concentration [ng/L] Load [g/d] 
Date 
Flow-
rate 
[m³/d] Influent Sett.-tank Effluent Influent Sett.-tank Effluent 
06.06.05 9313 46 21 24 0.4 0.2 0.2 
07.06.05 12117 43  18 0.5  0.2 
08.06.05 10089 61  20 0.6  0.2 
09.06.05 10079 60 24 15 0.6 0.2 0.1 
10.06.05 11845 70  22 0.8  0.3 
11.06.05 10749 63  24 0.7  0.3 
12.06.05 9219 40  28 0.4  0.3 
13.06.05 10778 74 34 29 0.8 0.4 0.3 
14.06.05 9188 54  29 0.5  0.3 
15.06.05 8865 62  62 0.5  0.5 
16.06.05 6206 78 37 30 0.5 0.2 0.2 
17.06.05 9364 87  32 0.8  0.3 
18.06.05 8453 45  36 0.4  0.3 
19.06.05 7944 50  27 0.4  0.2 
20.06.05 8577 68 41 37 0.6 0.4 0.3 
21.06.05 8633 45  34 0.4  0.3 
22.06.05 8403 53  32 0.4  0.3 
23.06.05 8398 43 38 27 0.4 0.3 0.2 
24.06.05 10980 55  29 0.6  0.3 
25.06.05 8750 67  23 0.6  0.2 
26.06.05 7748 54  26 0.4  0.2 
27.06.05 8525 66 29 26 0.6 0.2 0.2 
28.06.05 7937 35  22 0.3  0.2 
29.06.05 16601 31  24 0.5  0.4 
30.06.05 33529 14 17 12 0.5 0.6 0.4 
01.07.05 33782 22  18 0.7  0.6 
02.07.05 23242 45  16 1.0  0.4 
03.07.05 13651 43  12 0.6  0.2 
 
